<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65574</article-id><article-id pub-id-type="doi">10.7554/eLife.65574</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-219845"><name><surname>Ruberto</surname><given-names>Anthony A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219846"><name><surname>Gréchez-Cassiau</surname><given-names>Aline</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219847"><name><surname>Guérin</surname><given-names>Sophie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-202166"><name><surname>Martin</surname><given-names>Luc</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5725-3955</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219848"><name><surname>Revel</surname><given-names>Johana S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219849"><name><surname>Mehiri</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-185228"><name><surname>Subramaniam</surname><given-names>Malayannan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-219850"><name><surname>Delaunay</surname><given-names>Franck</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4927-1701</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-217853"><name><surname>Teboul</surname><given-names>Michèle</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3418-4384</contrib-id><email>Michele.Teboul@univ-cotedazur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Université Côte d’Azur, CNRS, Inserm, iBV</institution><addr-line><named-content content-type="city">Nice</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution>Université Côte d’Azur, CNRS, Institut de Chimie de Nice</institution><addr-line><named-content content-type="city">Nice</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution>Department of Biochemistry and Molecular Biology, Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>James</surname><given-names>David E</given-names></name><role>Senior Editor</role><aff><institution>The University of Sydney</institution><country>Australia</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>08</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65574</elocation-id><history><date date-type="received" iso-8601-date="2020-12-08"><day>08</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-08-15"><day>15</day><month>08</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2020-12-23"><day>23</day><month>12</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.12.22.423999"/></event></pub-history><permissions><copyright-statement>© 2021, Ruberto et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ruberto et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65574-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-65574-figures-v2.pdf"/><abstract><p>The mammalian circadian timing system and metabolism are highly interconnected, and disruption of this coupling is associated with negative health outcomes. Krüppel-like factors (KLFs) are transcription factors that govern metabolic homeostasis in various organs. Many KLFs show a circadian expression in the liver. Here, we show that the loss of the clock-controlled KLF10 in hepatocytes results in extensive reprogramming of the mouse liver circadian transcriptome, which in turn alters the temporal coordination of pathways associated with energy metabolism. We also show that glucose and fructose induce <italic>Klf10,</italic> which helps mitigate glucose intolerance and hepatic steatosis in mice challenged with a sugar beverage. Functional genomics further reveal that KLF10 target genes are primarily involved in central carbon metabolism. Together, these findings show that in the liver KLF10 integrates circadian timing and sugar metabolism-related signaling, and serves as a transcriptional brake that protects against the deleterious effects of increased sugar consumption.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>circadian rhythm</kwd><kwd>metabolism</kwd><kwd>krüppel like factors</kwd><kwd>liver</kwd><kwd>fructose</kwd><kwd>glucose</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-12-BSV1-0014</award-id><principal-award-recipient><name><surname>Delaunay</surname><given-names>Franck</given-names></name><name><surname>Teboul</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-11-LABX-0028-01</award-id><principal-award-recipient><name><surname>Ruberto</surname><given-names>Anthony A</given-names></name><name><surname>Delaunay</surname><given-names>Franck</given-names></name><name><surname>Teboul</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-15-IDEX-01</award-id><principal-award-recipient><name><surname>Delaunay</surname><given-names>Franck</given-names></name><name><surname>Teboul</surname><given-names>Michèle</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100006331</institution-id><institution>Canceropole PACA</institution></institution-wrap></funding-source><award-id>MetaboCell</award-id><principal-award-recipient><name><surname>Mehiri</surname><given-names>Mohamed</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100013371</institution-id><institution>Université Côte d’Azur</institution></institution-wrap></funding-source><award-id>ATER</award-id><principal-award-recipient><name><surname>Revel</surname><given-names>Johana S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Krüppel-like factor 10 coordinates the hepatic circadian transcriptome and protects the liver from the adverse effects of increased sugar consumption.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The mammalian circadian timing system aligns most biological processes with the Earth’s light/dark (LD) cycle to ensure optimal coordination of physiology and behavior over the course of the day (<xref ref-type="bibr" rid="bib3">Bass and Lazar, 2016</xref>). At the organism level, circadian clocks are organized hierarchically with a central pacemaker located in the suprachiasmatic nuclei of the hypothalamus that receives the light input and in turn coordinates peripheral clocks via internal synchronizers including glucocorticoids and body temperature (<xref ref-type="bibr" rid="bib67">Saini et al., 2011</xref>). The molecular mechanism underlying circadian clocks is an oscillatory gene network present in virtually all cells, which translates the external time information into optimally phased rhythms in chromatin remodeling, gene expression, post-translational modification, and metabolites production (<xref ref-type="bibr" rid="bib12">Dyar et al., 2018</xref>; <xref ref-type="bibr" rid="bib45">Mauvoisin and Gachon, 2020</xref>; <xref ref-type="bibr" rid="bib62">Rijo-Ferreira and Takahashi, 2019</xref>; <xref ref-type="bibr" rid="bib65">Robles et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Robles et al., 2014</xref>; <xref ref-type="bibr" rid="bib82">Weidemann et al., 2018</xref>; <xref ref-type="bibr" rid="bib87">Zhang et al., 2014</xref>).</p><p>The extensive circadian regulation of processes linked to metabolic homeostasis, as well as how the cellular metabolism feeds back to the clock, has been highlighted in functional genomics studies (<xref ref-type="bibr" rid="bib54">Panda, 2016</xref>; <xref ref-type="bibr" rid="bib55">Peek et al., 2013</xref>; <xref ref-type="bibr" rid="bib61">Reinke and Asher, 2019</xref>; <xref ref-type="bibr" rid="bib73">Sinturel et al., 2020</xref>). In mice, the disruption of clock genes leads to multiple metabolic abnormalities, including impaired insulin release, glucose intolerance, insulin resistance, hepatic steatosis, and obesity (<xref ref-type="bibr" rid="bib6">Bugge et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Jacobi et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Perelis et al., 2015</xref>); conversely, diet-induced metabolic imbalance impairs circadian coordination in part by reprogramming the circadian transcriptome (<xref ref-type="bibr" rid="bib13">Eckel-Mahan et al., 2013</xref>; <xref ref-type="bibr" rid="bib55">Peek et al., 2013</xref>). Experimental and epidemiological data support a similar reciprocal relationship between circadian misalignment or disruption and metabolic disorders in humans (<xref ref-type="bibr" rid="bib59">Qian and Scheer, 2016</xref>; <xref ref-type="bibr" rid="bib75">Stenvers et al., 2019</xref>).</p><p>The liver is a major metabolic organ in which circadian gene expression is regulated directly by core clock and clock-controlled transcription factors, among which nuclear hormone receptors including REV-ERBs, PPARs, GR, FXR, and SHP play a prominent role (<xref ref-type="bibr" rid="bib51">Mukherji et al., 2019</xref>). Krüppel-like factors (KLFs) form another family of transcription regulators, a majority of which are involved in the physiology of metabolic organs including the liver (<xref ref-type="bibr" rid="bib23">Hsieh et al., 2019</xref>). Many of these KLFs are also clock-controlled genes in mouse liver (<xref ref-type="bibr" rid="bib8">Ceglia et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Yoshitane et al., 2014</xref>). This suggests that the KLFs act as additional factors for the circadian regulation of hepatic metabolism. For instance, KLF15 was shown to control the circadian regulation of nitrogen metabolism and bile acid production (<xref ref-type="bibr" rid="bib20">Han et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Jeyaraj et al., 2012</xref>). KLF10, first described as a TGF-β-induced early gene in human osteoblasts and pro-apoptotic factor in pancreatic cancer (<xref ref-type="bibr" rid="bib76">Subramaniam et al., 1995</xref>; <xref ref-type="bibr" rid="bib78">Tachibana et al., 1997</xref>), has been further identified as a clock-controlled and glucose-induced transcription factor that helps suppress hepatic gluconeogenesis (<xref ref-type="bibr" rid="bib19">Guillaumond et al., 2010</xref>; <xref ref-type="bibr" rid="bib22">Hirota et al., 2002</xref>). In <italic>Drosophila</italic>, the KLF10 ortholog <italic>Cabut</italic> has a similar role in sugar metabolism and circadian regulation (<xref ref-type="bibr" rid="bib2">Bartok et al., 2015</xref>), which suggests that the function of this transcription factor is evolutionarily conserved.</p><p>A better understanding of the role of KLF10 in hepatic metabolism may have important translational implications in the context of the rising prevalence of nonalcoholic fatty liver disease (NAFLD) and fructose overconsumption (<xref ref-type="bibr" rid="bib28">Jensen et al., 2018</xref>). In this study, using a hepatocyte-specific <italic>Klf10</italic> knockout mouse model, we show that KLF10 is required for the temporal coordination of various biological pathways associated with energy metabolism and has a protective role in shielding mice from adverse effects associated with sugar overload.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Hepatocyte-specific deletion of KLF10 reprograms the liver circadian transcriptome</title><p>To understand the role of the circadian transcription factor KLF10 in hepatic metabolism, we generated a conditional <italic>Klf10</italic> knockout mouse model by crossing WT mice (<xref ref-type="bibr" rid="bib83">Weng et al., 2017</xref>) with a mouse line expressing an inducible CreER<sup>T2</sup> recombinase under the control of the endogenous serum albumin promoter (<xref ref-type="bibr" rid="bib71">Schuler et al., 2004</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Upon tamoxifen treatment of <italic>Klf10<sup>flox/flox</sup>, Alb<sup>+/CreERT2</sup></italic> mice, we obtained a deletion of <italic>Klf10</italic> specifically in hepatocytes (hepKO). Both qPCR and immunoblot analyses confirmed the targeted reduction of the transcription factor in the liver of hepKO mice (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, left, C). Residual expression was attributable to non-parenchymal cells as <italic>Klf10</italic> mRNA was not detectable in isolated primary hepatocytes (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, right). As expected, we detected a robust circadian oscillation of <italic>Klf10</italic> mRNA in the liver of WT mice, with peak expression of the transcript occurring just before the LD transition, while in hepKO mice, rhythmic expression of <italic>Klf10</italic> was absent (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Body weight, food intake, and food-seeking behavior did not differ between genotypes, indicating that postnatal hepatocyte-specific deletion of KLF10 did not grossly affect the physiology and behavior of unchallenged adult <italic>Klf10<sup>Δhep</sup></italic>mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Genetic disruption of <italic>Klf10</italic> in mouse hepatocytes.</title><p>(<bold>A</bold>) Schematic illustrating the strategy used for generating HepKO mice. (<bold>B</bold>) Relative gene expression of <italic>Klf10</italic> mRNA across various tissue in WT and HepKO mice as measured at ZT9 (left) and in WT and HepKO primary hepatocytes (PH) (right) (mean ± SEM, n = 3–5). (<bold>C</bold>) Immunoblot showing KLF10 protein abundance in liver extracts from WT and HepKO mice at ZT9 (left) and quantification of 3–4 independent experiments (right). EF1α was used as loading control. (<bold>D</bold>) 24 hr gene expression profiles of hepatic <italic>Klf10</italic> mRNA measured every 3 hr in WT and HepKO mice (mean ± SEM, n = 3 mice per time point). Statistics: nonparametric Wilcoxon test. *p&lt;0.05.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig1">Figure 1B and D</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Genetic disruption of <italic>Klf10</italic> in mouse hepatocytes.</title><p>(<bold>A</bold>) Body weights (left) and daily food intake (right) of WT and HepKO mice of WT and HepKO mice (mean ± SEM, n = 44 for body weight and n = 6–8 for food intake). (<bold>B</bold>) Representative actograms of double-plotted food-seeking activity records of WT and HepKO mice. Mice were placed in individual cages containing a Minimetter infrared detection system. Vertical bars represent time points that animals were in the area of the cage containing food. Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig1-figsupp1-v2.tif"/></fig></fig-group><p>We next performed RNA sequencing (RNA-seq) on livers collected every 3 hr across the 24 hr day from WT and hepKO mice entrained to a 12 hr:12 hr LD cycle (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Using MetaCycle (<xref ref-type="bibr" rid="bib84">Wu et al., 2016</xref>), we found that ~12% of genes (1,664) displayed circadian expression in WT mice (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>), a percentage that is consistent with previous reports (<xref ref-type="bibr" rid="bib18">Greenwell et al., 2019</xref>; <xref ref-type="bibr" rid="bib87">Zhang et al., 2014</xref>). In hepKO mice, we detected a similar percentage of genes with circadian expression (~12%; 1633) (<xref ref-type="fig" rid="fig2">Figure 2B</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). The phase distributions and relative amplitudes of rhythmically expressed genes in WT and hepKO mice were similar (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). Strikingly, we observed rhythmicity of 1031 transcripts exclusively in hepKO mice, indicating that the deletion of KLF10, a known transcriptional repressor, results in de novo oscillation of otherwise non-rhythmically expressed transcripts (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Approximately 37% (602) of genes displaying a rhythmic expression in both genotypes included various high-amplitude transcripts (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). We found the core clock genes within this subset (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>), suggesting that hepatocyte KLF10 is not required for normal core clock function in the liver. A set of 1062 transcripts with a low amplitude in WT mice displayed a dampened rhythmicity in hepKO mice, resulting in a MetaCycle p-value above threshold (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Together, this data indicates that the main effect of the hepatocyte KLF10 knockout is the derepression of the oscillatory behavior of a significant proportion of the liver transcriptome.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Deletion of hepatocyte KLF10 alters the circadian transcriptome in the liver.</title><p>(<bold>A</bold>) Schematic illustrating the workflow used to assess the circadian transcriptomes of livers in WT and HepKO mice. (<bold>B</bold>) Number of rhythmic transcripts detected in the livers from WT and HepKO mice. (<bold>C</bold>) Phase distributions of rhythmic transcripts in the livers of WT and HepKO mice. (<bold>D</bold>) Relative amplitudes of rhythmic transcripts in the livers of WT and HepKO mice. (<bold>E</bold>) Number of unique and overlapping rhythmic transcripts in WT and HepKO mice. (<bold>F</bold>) Heatmaps of transcripts showing de novo, unchanged or dampened oscillatory behavior in the liver of HepKO mice compared to WT mice (pools of three livers per time point). (<bold>G</bold>) Magnitudes and phases of enriched biological processes identified by Phase Set Enrichment Analysis (PSEA) in WT mice only (top), in HepKO mice only (bottom), and in both genotypes (middle). Statistics: MetaCycle, significance threshold, p&lt;0.05; PSEA; Kuiper test, significance threshold, <italic>q</italic> &lt; 0.01.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>MetaCycle analysis of the hepatic circadian transcriptome of WT and HepKO mice fed ad libitum and entrained in a 12:12 light/dark (LD) cycle.</title><p>(.xlsx 9.65 MB).</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig2-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Phase Set Enrichment Analysis (PSEA) of the hepatic transcriptome of WT and HepKO mice fed ad libitum and entrained in a 12:12 light/dark (LD) cycle.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig2-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Deletion of hepatocyte KLF10 alters the circadian transcriptome in the liver.</title><p>(<bold>A</bold>) Gene expression profiles of clock genes in the livers of WT and HepKO mice (n = 3 pools of liver per time point). (<bold>B</bold>) Gene expression profiles of genes representative of the heatmaps in <xref ref-type="fig" rid="fig2">Figure 2F</xref> in WT and HepKO mice (mean ± SEM, n = 2–4 per time point). (<bold>C</bold>) Glycemia in WT and HepKO mice measured at ZT6 and ZT18 (mean ± SEM, n = 14). (<bold>D</bold>) Liver glycogen content in WT and HepKO mice measured at ZT3 and ZT15 (mean ± SEM, n = 5–6). (<bold>E</bold>) Glucose uptake in WT and HepKO primary hepatocytes (mean ± SEM, n = 4). (<bold>F</bold>) Glucose production in WT and HepKO primary hepatocytes (mean ± SEM, n = 6). Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05; ***p&lt;0.005.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B-F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig2-figsupp1-v2.tif"/></fig></fig-group><p>To better understand the changes in the circadian transcriptome associated with the deletion of <italic>Klf10</italic> in hepatocytes, we assessed the temporal coordination of biologically related transcripts in WT and hepKO mice. After performing Phase Set Enrichment Analysis (PSEA) (<xref ref-type="bibr" rid="bib89">Zhang et al., 2016</xref>), we found a decrease in the total number of temporally enriched gene sets in hepKO mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Specifically, gene sets associated with processes such as oxidative phosphorylation, fatty acid metabolism, and mTORC1 signaling peaking around the LD transition in WT mice were absent in hepKO mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Despite the global reduction in temporally coordinated transcripts, hepKO mice acquired de novo temporal enrichment of transcripts associated with glycolysis and cellular stress processes such as apoptosis, UV response, and inflammation (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>).</p><p>The alterations of biological pathways at the transcript level in hepKO mice prompted us to assess whether any changes associated with these pathways would be visible at the physiological level. Given the scope of our research question, we focused primarily on processes linked to glucose homeostasis. hepKO mice exhibited a modest increase of plasma glucose and a decrease in glycogen levels during their resting phase but not during the active phase (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C and D</xref>). The absence of hepatic KLF10 had no impact on the adaptation of HepKO mice to a 19 hr fast (glycemia: WT = 112 ± 7 mg/dl; hepKO = 113 ± 6 mg/dl). Additionally, we observed that hepKO hepatocytes displayed an increased glucose uptake and glucose production (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E and F</xref>). These observations suggest that the loss of KLF10 in hepatocytes leads to subtle physiological changes in carbohydrate processing at the cellular, tissue, and organism level. Together, these findings indicate that dysregulation of the hepatic circadian transcriptome in hepKO mice results in the rewiring of various pathways related to energy metabolism, which in turn may compromise the ability of these animals to adapt to dietary challenges.</p></sec><sec id="s2-2"><title>Hepatocyte KLF10 minimizes the adverse metabolic effects associated with a high sugar diet</title><p>Consumption of glucose and fructose in the form of sugar-sweetened beverages is linked to negative health outcomes (<xref ref-type="bibr" rid="bib74">Softic et al., 2020</xref>). While previous studies have shown that glucose is a potent inducer of <italic>Klf10</italic> expression in primary hepatocytes (<xref ref-type="bibr" rid="bib19">Guillaumond et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Iizuka et al., 2011</xref>), the effect of fructose is unknown. We now show that primary hepatocytes treated with a mix of 5 mM (low) glucose and 5 mM fructose induces <italic>Klf10</italic> to the same extent as high (25 mM) glucose alone (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Furthermore, treating cells with high glucose and 5 mM fructose has an additive effect (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Glucose and fructose are potent inducers of <italic>Klf10</italic> expression in hepatocytes.</title><p>Expression of the <italic>Klf10</italic> mRNA in primary WT mouse hepatocytes challenged with low (5 mM) or high (25 mM) glucose (Glu) in the absence or presence of 5 mM fructose (Fru) (mean ± SEM, n = 6) Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05, **p&lt;0.01.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig3-v2.tif"/></fig><p>Given these results in hepatocytes, combined with transcriptional changes occurring in unchallenged hepKO mice, we sought to better understand the role of KLF10 in mediating the effect of the two dietary sugars at the organism level. WT and hepKO mice were given ad libitum access to a chow diet with water (chow) or a chow diet with sugar-sweetened water (chow + SSW) for 8 weeks (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Similar to the response we observed in hepatocytes, the chow + SSW diet strongly induced hepatic <italic>Klf10</italic> mRNA expression when measured during the animals’ feeding phase (ZT15) but not at the end of its fasting period—when <italic>Klf10</italic> is peaking (ZT9) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Mice on the chow + SSW diet adapted their feeding behavior, with less calories coming from the chow pellets. As a result, their total calorie intake was unchanged relative to mice fed the chow diet (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). After 8 weeks on the chow + SSW diet, mice from both genotypes displayed a significant increase in body mass and epididymal fat pad mass (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). We also observed a trend for an increase in liver mass of mice fed a chow + SSW diet that reached significance in hepKO mice (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). The chow + SSW diet increased liver triglycerides content, and histological signs of steatosis were evident in both genotypes; however, to a greater extent in hepKO mice (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Despite the greater increase in liver triglycerides in hepKO mice, no difference in circulating triglycerides was detected between genotypes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of hepatocyte KLF10 exacerbates the adverse effects associated with increased sugar consumption.</title><p>(<bold>A</bold>) Schematic illustrating the design of the sugar-sweetened water (SSW) challenge experiment. (<bold>B</bold>) Gene expression of <italic>Klf10</italic> at ZT9 and ZT15 in livers of WT and HepKO mice given a chow or chow + SSW diet (mean ± SEM, n = 4–8). (<bold>C</bold>) Body mass of mice given a chow or chow + SSW diet (mean ± SEM, n = 9–12). (<bold>D</bold>) Epididymal white adipose tissue mass of mice given a chow or chow + SSW diet (mean ± SEM, n = 9–12). (<bold>E</bold>) Liver mass of mice given a chow or chow + SSW diet (mean ± SEM, n = 8–12). (<bold>F</bold>) Liver triglyceride content (mean ± SEM, n = 6–10) (left) and representative images of liver histology (right) in WT and HepKO mice given a chow or chow + SSW diet (scale bar = 50 µm). (<bold>G</bold>) Blood glucose in WT and HepKO mice given a chow or chow + SSW diet (n = 9–12). (<bold>H</bold>) Insulin levels in WT and HepKO mice given a chow or chow + SSW diet (mean ± SEM, n = 9–12). (<bold>I</bold>) Blood glucose levels assessed at regular intervals over a 2 hr period in mice undergoing a glucose tolerance test (GTT) performed at ZT12 (left) and area under the curve of blood glucose levels over the measurement period (right) (mean ± SEM, n = 9–12). (<bold>J</bold>) Heatmap showing the normalized concentration of metabolites in the liver of WT and HepKO mice given a chow or chow + SSW diet (mean, n = 9–12). Significant pairwise comparisons are boxed. (<bold>C–H, J</bold>), Measurements were performed during the animals’ feeding period, at ZT15. Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Loss of hepatocyte KLF10 exacerbates the adverse effects associated with increased sugar consumption.</title><p>(<bold>A</bold>) Daily caloric intake in WT and HepKO mice under the chow and chow + sugar-sweetened water (SSW) dietary conditions (mean ± SEM, n = 8–14). (<bold>B</bold>) Blood triglyceride content at ZT15 in WT and HepKO mice under the chow and chow + SSW dietary conditions (mean ± SEM, n = 6).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To further profile these mice, we assessed various parameters associated with sugar metabolism during the animals’ early active (feeding) phase (ZT12-15)—a time of day when insulin sensitivity is at its maximum (<xref ref-type="bibr" rid="bib36">la Fleur et al., 2001</xref>), and when pathways associated with nutrient intake and processing are activated (<xref ref-type="bibr" rid="bib18">Greenwell et al., 2019</xref>; <xref ref-type="bibr" rid="bib80">Vollmers et al., 2009</xref>). Glycemia was moderately increased in hepKO mice on chow diet as compared to WT mice fed the same diet (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Compared to WT mice, hepKO mice on the chow + SSW diet displayed hyperinsulinemia (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Furthermore, hepKO mice on the chow + SSW diet exhibited greater glucose intolerance compared to WT mice on the same diet (<xref ref-type="fig" rid="fig4">Figure 4I</xref>, <italic>pAnova</italic> [genotype:diet] = 0.00275). Next we profiled carbohydrate, amino acid, and TCA-related metabolite levels in the four experimental groups of mice. We found that hexose-6-phosphate, myo-inositol, UDP-D-hexose, and citric acid were increased and that phospho-enol-pyruvate was decreased to a similar extent in both WT and hepKO mice on the chow + SSW diet relative to their respective counterpart fed a chow diet (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). In contrast, glutamine was increased only in WT on the chow + SSW diet, while phenylalanine and fumarate were increased and decreased respectively only in hepKO mice on the chow + SSW diet (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). These observations reveal subtle changes in amino acid catabolism in mice lacking hepatocyte KLF10.</p><p>We next assessed the effect of the chow + SSW diet at the transcriptional level in WT and hepKO mice by comparing the expression of various gene associated with metabolism. We detected an upregulation of <italic>Slc2a4</italic>—a gene encoding for a glucose transporter not normally expressed in the liver yet with well-described expression in adipose and skeletal muscle (<xref ref-type="bibr" rid="bib33">Klip et al., 2019</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Furthermore, the absence of KLF10 in hepatocytes dramatically increased the expression of <italic>Slc2a4</italic> in hepKO mice on chow + SSW compared to WT mice on the same diet at both ZT9 and ZT15 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The chow + SSW diet resulted in similar upregulation of glucose (<italic>Slc2a2</italic>) and fructose (<italic>Slc2a5</italic>) transporters in both WT and hepKO mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). We found that the gene encoding for the rate-limiting glycolytic enzyme encoding <italic>Pklr</italic> was similarly upregulated by the chow + SSW challenge in both WT and HepKO mice at ZT9 while hepKO mice on the chow + SSW diet displayed higher expression of compared to WT mice on the same diet at ZT15 (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Expression of the gluconeogenic gene <italic>Pck1</italic>, a known direct KLF10 target gene (<xref ref-type="bibr" rid="bib19">Guillaumond et al., 2010</xref>), was downregulated at ZT9 in WT mice on the chow + SSW diet as expected but was unchanged in hepKO mice on the same diet (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). At ZT15, <italic>Pck1</italic> mRNA expression was only induced in hepKO mice on the chow + SSW diet (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). No genotype effect was observed for glucokinase (<italic>Gck</italic>), ketohexokinase (<italic>Khk</italic>), and glucose-6-phosphatase (<italic>G6pc</italic>) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Hepatocyte-specific deletion of KLF10 also altered the transcriptional response of genes involved in de novo lipogenesis as hepKO mice fed the chow + SSW diet displayed a significantly greater induction of the genes encoding for fatty acid synthase (<italic>Fasn)</italic> and <italic>fatty acid elongase (Elovl6</italic>) at ZT15 as compared to their WT controls on the same diet (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Additionally, we observed a greater expression of ATP citrate lyase (<italic>Acly</italic>), acetyl-CoA carboxylase alpha (<italic>Acaca</italic>), malic enzyme (<italic>Me1</italic>), and thyroid hormone response SPOT14 (<italic>Thrsp</italic>) measured at ZT15 in hepKO mice on the chow + SSW diet as compared to WT mice on the same diet (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Altered metabolic gene expression in HepKO mice challenged with high sugar.</title><p>(<bold>A</bold>) Expression profiles of <italic>Slc2a4</italic> and <italic>Pklr</italic>. (<bold>B</bold>) Expression profile of <italic>Pck1</italic>. (<bold>C</bold>) Expression profiles of the <italic>Fasn</italic> and <italic>Elovl6</italic>. (<bold>A–C</bold>) Expression was determined at ZT9 and ZT15 in the liver of WT and HepKO mice given a chow or chow + sugar-sweetened water (SSW) diet (mean ± SEM, n = 3–6). The # symbol denotes a direct KLF10 target. Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Altered metabolic gene expression in HepKO mice challenged with high sugar.</title><p>(<bold>A</bold>) Expression of <italic>Slc2a2</italic> and <italic>Slc2a5</italic>. (<bold>B</bold>) Expression of <italic>Gck, Khk,</italic> and <italic>G6pc</italic>. (<bold>C</bold>) Expression of <italic>Acaca, Acly</italic>, <italic>Me1,</italic> and <italic>Thrsp</italic>. (<bold>A–C</bold>) Expression determined at ZT15 in WT and HepKO mice given a chow or chow + sugar-sweetened water (SSW) diet (mean ± SEM, n = 6–8). The # symbol denotes a direct KLF10 target. Statistics: nnparametric Kruskal–Wallis test. *p&lt;0.05; ***p&lt;0.005.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig5-figsupp1-v2.tif"/></fig></fig-group><p>Taken together, our physiological, metabolic, and molecular data suggests that the induction of KLF10 in response to a dietary sugar challenge serves as a protective mechanism that aids in safeguarding the organism from the detrimental effects associated with excess sugar intake.</p></sec><sec id="s2-3"><title>KLF10 is a ‘transcriptional brake’ that fine-tunes sugar signaling in hepatocytes</title><p>As the induction of hepatic KLF10 in chow + SSW-fed mice helps to minimize the adverse metabolic effects associated with excess dietary sugar intake, we hypothesized that this transcription factor may be involved in the metabolic adaptation of hepatocytes to acute changes in carbohydrate availability. To test this hypothesis in a cell-autonomous manner, we treated WT and hepKO primary hepatocytes with either 5 mM glucose (low glucose [LG]) or 25 mM glucose and 5 mM fructose (high glucose and fructose [HGF]) for 12 hr (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>) and performed RNA-seq to profile the transcriptomes under each condition.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>KLF10 governs the transcriptional response to hexose sugars in hepatocytes.</title><p>(<bold>A</bold>) Schematic illustrating the design of the in vitro sugar challenge experiment in WT and HepKO hepatocytes treated with low glucose (LG) or high glucose and fructose (HGF). (<bold>B</bold>) Representative immunoblot showing KLF10 protein abundance in WT hepatocytes treated with LG or HGF and in HepKO primary hepatocytes treated with HGF. EF1α was used as loading control. (<bold>C</bold>) Top: volcano plots showing changes in gene expression in WT and HepKO hepatocytes treated with LG or HGF. Positive fold change (FC) values represent genes upregulated under HGF condition, and negative FC values represent genes upregulated under LG conditions. Genes significantly upregulated (FDR &lt; 0.5) and displaying an FC &gt; 2 in HGF (red dots) and in LG (blue dots) conditions. Dashed horizontal lines: FDR = 0.05; dashed vertical lines: FC = 2. Boxed areas highlight the larger number of downregulated genes in WT compared to HepKO hepatocytes. Bottom: summary of differential gene expression (DGE) data shown in the volcano plots and of the enrichment analysis. (<bold>D</bold>) Kyoto Encyclopedia of Genes and Genomes-enriched pathways in WT and HepKO primary hepatocytes treated with LG or HGF. (<bold>E</bold>) Expression profiles of genes associated with key metabolic pathways in WT and HepKO primary hepatocytes treated with LG or HGF (mean ± SEM, n = 3). (<bold>F</bold>) A schematic of key metabolic pathways in hepatocytes. Genes significantly upregulated in HepKO vs. WT hepatocytes when treated with HGF are highlighted on the schematic. DHAP: dihydoxyacetone phosphate; LCFA: long-chain fatty acids; GA: glyceraldehyde; OAA: oxaloacetic acid; PEP: phosphor-enol-pyruvate. In (<bold>E</bold>) and (<bold>F</bold>), the # symbol denotes a direct KLF10 target. Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.005.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Differentially expressed genes in WT and HepKO hepatocytes challenged with high sugar compared to unchallenged cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Kyoto Encyclopedia of Genes and Genomes-enriched pathway in WT and HepKO hepatocytes challenged with high sugar compared to unchallenged cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig6-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig6">Figure 6E</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig6-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>KLF10 governs the transcriptional response to hexose sugars in hepatocytes.</title><p>Expression of <italic>Elovl6</italic> in WT and HepKO primary hepatocytes treated with low glucose (LG) or high glucose and fructose (HGF) (mean ± SEM, n = 3). Statistics: nonparametric Kruskal–Wallis test. **p&lt;0.01; ***p&lt; 0.005.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig6-figsupp1-v2.tif"/></fig></fig-group><p>The switch from the LG to the HGF condition led to a differential expression of 845 and 608 genes in WT and hepKO hepatocytes, respectively (<xref ref-type="fig" rid="fig6">Figure 6C</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Notably, the number of downregulated genes was decreased by ~40% in challenged hepKO hepatocytes compared to WT hepatocytes, suggesting that the ability of hepKO hepatocytes to repress gene expression in response to the HGF challenge is compromised (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Using the significantly altered transcripts detected under the LG and HGF conditions as an input, we performed pathway enrichment analysis and found several differences between WT and hepKO hepatocytes (<xref ref-type="fig" rid="fig6">Figure 6C</xref> and <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>). In the LG condition, pathways associated with amino acid catabolism, fatty acid oxidation, and peroxisome metabolism were significantly enriched in WT but not hepKO hepatocytes (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, left, and <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>). Underlying these changes, WT hepatocytes displayed an upregulation of genes coding enzymes linked to branched chain amino acids (<italic>Mccc2, Ivd, Acat1, Fah, Echs1, Adlh9a1</italic>), alanine, lysine and tryptophan (<italic>Echs1, Adlh9a1</italic>), and tyrosine (<italic>Fah</italic>) degradation<italic>,</italic> as well as genes encoding for enzymes linked to mitochondrial and peroxisomal fatty acid oxidation (<italic>Cpt1a</italic>, <italic>Echs1, Adlh9a1, Decr2</italic>) (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref>). In the HGF condition, hepKO hepatocytes displayed a greater number of enriched pathways relative to WT hepatocytes, with many of these de novo pathways associated with carbohydrate metabolism (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, right). Similar to our results in mice challenged with the chow + SSW diet, the HGF condition resulted in an upregulation of the glucose transporter <italic>Slc2a4</italic> in the WT and hepKO hepatocytes, with the absence of KLF10 further augmenting this response (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). In a similar manner, hepKO hepatocytes in the HGF condition displayed greater induction of genes associated with fructose (<italic>Khk, Tfkc</italic>) and glycogen (<italic>Ppp1r3c</italic>) metabolism relative to WT hepatocytes (<xref ref-type="fig" rid="fig6">Figure 6D and E</xref>). In addition to the enhanced upregulation of genes associated with carbohydrate metabolism, hepKO hepatocytes had a greater induction of genes associated with de novo lipogenesis (<italic>Acly, Acaca, Fasn, Thrsp</italic>) and long-chain fatty acid elongation (<italic>Elovl6</italic>) (<xref ref-type="fig" rid="fig6">Figure 6E and F</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><p>Collectively, our in vitro challenge data supports the notion that KLF10 acts as a brake that aids in fine-tuning the hepatocyte’s transcriptional response to glucose and fructose. Furthermore, the dysregulation of various metabolic pathways in hepatocytes lacking KLF10 corroborates the abnormal physiological response of hepKO mice challenged with the chow + SSW diet.</p></sec><sec id="s2-4"><title>KLF10 targets an extensive metabolic gene network in the liver</title><p>To further explore the role of KLF10 in the regulation of hepatic metabolism at the transcriptome level, we assessed the genome-wide occupancy of KLF10 in mouse liver using chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We performed the analysis at ZT9, which is close to the protein acrophase (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). We identified a repertoire of 35,523 KLF10 binding sites matching the KLF10 matrix (<xref ref-type="bibr" rid="bib70">Schmitges et al., 2016</xref>) and located in the –50/+ 1 kb region of associated genes (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The density of KLF10 binding sites was negatively correlated with their distance from the transcription initiation site with 37% being located in the –10/+ 1 kb region, thus indicating that KLF10 mainly binds proximal promoter regions (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). The 13,230 KLF10 binding sites present in the –10/+ 1 kb proximal region were associated to 7898 unique genes. To obtain a comprehensive view of the metabolic role of KLF10, we integrated in a single network the ChIP-seq data for these 7898 genes, the DGE data in hepKO vs. WT hepatocytes challenged with high sugar (HGF condition in <xref ref-type="fig" rid="fig6">Figure 6</xref>) and the HumanCyc metabolic pathways containing 6161 nodes including 2566 genes and 81,590 edges (<xref ref-type="bibr" rid="bib66">Romero et al., 2005</xref>). The resulting KLF10 network visualized in Cytoscape containing 798 nodes and 10,980 edges revealed that genes regulated or/and bound by KLF10 were present in 23 annotated subnetworks (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>, and <xref ref-type="supplementary-material" rid="fig7sdata2">Figure 7—source data 2</xref>). However, half of these KLF10 regulated/bound genes present in the network clustered in three major processes associated with lipid and amino acid metabolism as well as protein phosphorylation (<xref ref-type="fig" rid="fig7">Figure 7C</xref> and Cytoscape network supplement file). The intersect between differentially expressed genes in hepKO vs. WT HGF-treated hepatocytes and KLF10 bound genes revealed 93 direct targets (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, top). This resulting list contained genes primarily associated with carboxylic acid metabolism, suggesting a role for KLF10 in central carbon metabolism (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, bottom). In line with these observations, two of the top ranked direct target genes included <italic>acyl-CoA synthetase short chain family member 2</italic> (<italic>Acss2</italic>) and <italic>acetyl-CoA carboxylase beta</italic> (<italic>Acacb</italic>), which encode for two key enzymes of acetyl-CoA metabolism (<xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>). ChIP experiments targeting the KLF10 binding sites identified within the <italic>Acss2</italic> and <italic>Acacb</italic> genes using the ChIP-seq profiling experiment confirmed that both genes were bound by KLF10 at ZT15 in the liver of WT mice on chow + SSW diet (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). Consistently, these two genes showed a greater upregulation at ZT15 in the liver of hepKO mice on chow + SSW diet compared to WT mice on the same diet, demonstrating that KLF10 is a transcriptional repressor of these two genes upon induction by high sugar during the feeding phase (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). Interestingly, ACSS2 is one of the highly connected nodes in the KLF10 metabolic network, suggesting that KLF10-dependent repression of <italic>Acss2</italic> may indirectly impact multiple components of hepatic energy metabolism (<xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig7sdata2">Figure 7—source data 2</xref>). We conclude from this data that KLF10 has an extensive repertoire of metabolic targets in the liver, many of which include key regulators of acetyl-CoA metabolism.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>KLF10 regulates a large metabolic network in the liver.</title><p>(<bold>A</bold>) Schematic illustrating the workflow used to identify KLF10 bound loci in mouse liver at ZT9. (<bold>B</bold>) Jaspar logo representing the KLF10 response element DNA sequence and distribution of KLF10 binding sites in mouse liver as a function of distance to the transcription start site. (<bold>C</bold>) Visualization of the KLF10 metabolic network constructed with Cytoscape using as inputs ChIP-seq data from mouse liver at ZT9, DGE data in high glucose and fructose (HGF)-treated hepatocytes and the HumanCyc metabolic network, (<bold>D</bold>) Venn diagram showing the number of direct KLF10 targets (top) and their associated GO biological process annotation (bottom). (<bold>E</bold>) ChIP-seq tracks near the <italic>Acss2</italic> and <italic>Acacb</italic> promoters (left) and ChIP of the boxed region at ZT15 in the liver of WT mice fed the chow + sugar-sweetened water (SSW) diet (right) (mean ± SEM, n = 4–6). (<bold>F</bold>) Expression of <italic>Acss2</italic> and <italic>Acacb</italic> at ZT9 and ZT15 in the liver of WT and HepKO mice given a chow or chow + SSW diet (mean ± SEM, n = 4–6). Statistics: nonparametric Kruskal–Wallis test. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.005.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Genes bound by KLF10 in their –10/+1 kb region or differentially expressed in WT vs. HepKO hepatocytes challenged with high sugar.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig7-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Cytoscape file used to generate, visualize, and analyze the KLF10 regulated metabolic network.</title></caption><media mime-subtype="cys" mimetype="application" xlink:href="elife-65574-fig7-data2-v2.cys"/></supplementary-material></p><p><supplementary-material id="fig7sdata3"><label>Figure 7—source data 3.</label><caption><title>Values and statistical test results for <xref ref-type="fig" rid="fig7">Figure 7E and F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-fig7-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>KLF10 regulates a large metabolic network in liver.</title><p>(Top) Immunoblot showing the oscillation of KLF10 protein abundance in the liver of mice entrained in a light/dark (LD) 12:12 cycle. (Bottom) Quantification and cosinor analysis of two independent time series.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-fig7-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>There is newfound appreciation of KLFs as transcriptional regulators of energy metabolism (<xref ref-type="bibr" rid="bib23">Hsieh et al., 2019</xref>). This role is underscored by the identification of KLF variants involved in cardiometabolic disorders (<xref ref-type="bibr" rid="bib52">Oishi and Manabe, 2018</xref>). In the liver, several of the <italic>Klf</italic> genes are direct targets of the CLOCK transcription factor (<xref ref-type="bibr" rid="bib86">Yoshitane et al., 2014</xref>), suggesting that timed expression of these transcription factors may help facilitate the connection between the circadian clock and metabolism (<xref ref-type="bibr" rid="bib29">Jeyaraj et al., 2012</xref>; <xref ref-type="bibr" rid="bib54">Panda, 2016</xref>; <xref ref-type="bibr" rid="bib61">Reinke and Asher, 2019</xref>; <xref ref-type="bibr" rid="bib73">Sinturel et al., 2020</xref>).</p><p>In this study, we show that KLF10 is required for the circadian coordination of biological processes associated with energy metabolism in the liver while dispensable for an intact hepatic clock function. This confirms our initial hypothesis that KLF10 acts primarily as a clock output (<xref ref-type="bibr" rid="bib19">Guillaumond et al., 2010</xref>). Alteration of the rhythmic hepatic transcriptome in hepKO mice also led to de novo oscillation for a large number of genes, in a manner similar to the transcriptional changes occurring in KLF15-deficient cardiomyocytes (<xref ref-type="bibr" rid="bib88">Zhang et al., 2015</xref>). In addition to the genetic disruption of clock-controlled KLFs, a variety of other systemic perturbations—such as high fat and ketogenic diets, arrhythmic feeding, caloric restriction, alcohol consumption, lung cancer, and rheumatoid arthritis—may result in de novo circadian oscillations in the liver (<xref ref-type="bibr" rid="bib13">Eckel-Mahan et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Gaucher et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Greenwell et al., 2019</xref>; <xref ref-type="bibr" rid="bib43">Makwana et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Masri et al., 2016</xref>; <xref ref-type="bibr" rid="bib58">Poolman et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Tognini et al., 2017</xref>). We therefore interpret the de novo oscillation seen in hepKO mice as the signature of their hepatic vulnerability as unchallenged hepKO mice appear healthy but are prone to develop hepatic steatosis associated with significant changes in metabolic gene expression when fed with high sugar. It is presently unknown whether the extensive reprogramming of the hepatic circadian transcriptome seen in many genetic or disease mouse models also occurs in humans. Should this occur, it may have important biomedical implications if diagnostic biomarkers or/and regulators of drug pharmacology that are expressed at low levels and arrhythmic in healthy subjects would become circadian upon disease initiation and progression, advocating for the integration of circadian timing in translational research (<xref ref-type="bibr" rid="bib7">Cederroth et al., 2019</xref>).</p><p>The link between altered metabolic homeostasis and inflammation is well established (<xref ref-type="bibr" rid="bib68">Saltiel and Olefsky, 2017</xref>). Recent studies have highlighted the role of KLF10 in regulating inflammation (<xref ref-type="bibr" rid="bib24">Huang et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Wara et al., 2020</xref>; <xref ref-type="bibr" rid="bib85">Yang et al., 2020</xref>) and in attenuating liver injury in mice with NASH ad fibrosis (<xref ref-type="bibr" rid="bib39">Lee et al., 2020</xref>). In this study, we found apoptosis and inflammation-related processes as gene sets that gain circadian coordination in unchallenged hepKO mice. Interestingly, inflammation markers also become rhythmic in a model of non-alcoholic steatohepatitis (NASH) (<xref ref-type="bibr" rid="bib38">Leclère et al., 2020</xref>). The adverse metabolic phenotype displayed by hepKO mice on chow + SSW diet may therefore include an inflammatory component.</p><p>Hepatocyte KLF10 functions on several levels to protect the liver from the negative effects of excess dietary sugars. We found that it inhibits glucose uptake, and we obtained correlative evidence that this could be achieved by preventing the expression of the adipose and muscle-specific <italic>Glut4</italic> glucose transporter in hepatocytes. Previous studies have shown that <italic>Klf10</italic> is a glucose-responsive gene (<xref ref-type="bibr" rid="bib19">Guillaumond et al., 2010</xref>; <xref ref-type="bibr" rid="bib22">Hirota et al., 2002</xref>), a finding that together with our recent observation strongly suggests that KLF10 directs a negative feedback loop limiting excessive glucose uptake. Consistent with this role, glycolytic gene expression was upregulated in hepKO mice. In addition to glucose, we show that <italic>Klf10</italic> is induced by fructose, and the combination of these two hexose sugars amplifies this response. This upregulation is crucial in blunting the negative effects associated with sugar intake as hepKO mice challenged with a sugar-sweetened beverage containing glucose and fructose as exemplified by signs of insulin resistance and increased hepatic steatosis in these animals.</p><p>Our functional genomics data indicate that one role of KLF10 in liver is to repress the lipogenic gene network. During the metabolic adaptation of the liver to high sugar, the glucose-inducible factor carbohydrate-responsive element-binding protein (ChREBP) plays a critical role by inducing lipogenic genes (<xref ref-type="bibr" rid="bib41">Ma et al., 2006</xref>; <xref ref-type="bibr" rid="bib53">Ortega-Prieto and Postic, 2019</xref>). Interestingly, the induction of <italic>Klf10</italic> is also mediated by ChREBP (<xref ref-type="bibr" rid="bib26">Iizuka et al., 2011</xref>). We therefore hypothesize a scenario in which sugar-induced steatosis is attenuated by KLF10, which acts both upstream of ChREBP—through repression of glucose uptake and downstream of ChREBP—via the repression of de novo lipogenesis.</p><p>Further, fructose is also converted by the gut microbiota to acetate which fuels ACLY-independent lipogenesis upon conversion to acetyl-coA by liver ACSS2 (<xref ref-type="bibr" rid="bib91">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Zhao et al., 2016</xref>). Our findings indicate that KLF10 is a transcriptional repressor of <italic>Acss2,</italic> suggesting an additional mechanism used by KLF10 in aiding to suppress fructose-induced lipogenesis. Our findings are directly relevant to human health as the increased consumption of fructose in the form of both sweetened beverages and processed foods unarguably contributes to the current pandemic of obesity and NAFLD (<xref ref-type="bibr" rid="bib21">Hannou et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Jensen et al., 2018</xref>; <xref ref-type="bibr" rid="bib50">Mortera et al., 2019</xref>). Links between the circadian clock and NAFLD have been suggested, but they are mostly based on preclinical models with disrupted core clock genes, a situation that is unlikely in humans (<xref ref-type="bibr" rid="bib46">Mazzoccoli et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Mukherji et al., 2019</xref>). The extensive rewiring of circadian gene expression and altered expression of clock-controlled regulators such as KLF10 associated with the onset or during disease states may disconnect circadian timing from metabolism and thereby contribute to chronic liver disease.</p><p>In summary, our work defines KLF10 as a dual transcriptional regulator with a circadian arm participating in the circadian coordination of liver metabolism and a homeostatic arm serving as a negative feedback control of sugar-induced lipogenesis. This duality is likely to be coordinated in healthy hepatocytes so that KLF10 peaks at the fasting/feeding transition when sugar metabolism shifts from gluconeogenesis to glycolysis. The desynchrony between circadian timing and the fasting/feeding cycle presumably impairs KLF10 functionality and thus may further exacerbate metabolic disease phenotype.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus,</italic> C57BL/6)</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib83">Weng et al., 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Klf10flox/flox controls; used males for experiments</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus, C57BL/6</italic>)</td><td align="left" valign="bottom"><italic>Alb-CreER<sup>T2</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib71">Schuler et al., 2004</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus, C57BL/6</italic>)</td><td align="left" valign="bottom">hepKO</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used males for experiments</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Primary heaptocytes from males; used 150,000–250,000 cells per plate as indicated</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">hepKO</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Primary hepatocytes from males; used 150,000–250,000 cells per plate as indicated</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Liver, heart, kidney, spleen, lung, white adipose tissue</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Blood</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-KLF10 (mouse monoclonal)</td><td align="left" valign="bottom">CDI Laboratories</td><td align="left" valign="bottom">Cat. #m14-355</td><td align="left" valign="bottom">WB (1:800)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-EGF1a (mouse monoclonal)</td><td align="left" valign="bottom">Upstate signaling solutions</td><td align="left" valign="bottom">Cat. #05-235</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IgG (goat polyclonal)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat. #A4416</td><td align="left" valign="bottom">WB (1:40,000)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Glucose Hexokinase Assay Kit</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat. #GAHK20-1KT</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PowerUp SYBR green Master Mix</td><td align="left" valign="bottom">Applied Biosystems</td><td align="left" valign="bottom">Cat. #A25779</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAquick PCR Purification Kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Cat. #2810</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Triglycerides colorimetric assay kit</td><td align="left" valign="bottom">Cayman</td><td align="left" valign="bottom">Cat. #10010303</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NucleoSpin RNA</td><td align="left" valign="bottom">Macherey-Nagel</td><td align="left" valign="bottom">Cat. #740955250</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy mini kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat. #74104</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Ultra RNA Library Prep Kit for Illumina</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">Cat. #E7530S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QubitTM dsDNA HS Assay Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat. #Q32854</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Glucose Uptake-Glo Assay</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat. #J1341</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Mouse Insulin Elisa</td><td align="left" valign="bottom">Mercodia</td><td align="left" valign="bottom">Cat. #10-1247-01</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Glucose (GOD-PAP)</td><td align="left" valign="bottom">Randox</td><td align="left" valign="bottom">Cat. #8318</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM, low glucose, GlutaMAX Supplement, pyruvate</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #21885025</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM, high glucose, GlutaMAX Supplement, pyruvate</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #10569010</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMEM, glucose-free</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #11966025</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">William’s E medium</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #22551022</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dexamethasone</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat. #D0700000</td><td align="left" valign="bottom">Used 10 nM final concentration</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Insulin-selenium-transferrin mix</td><td align="left" valign="bottom">Gibco</td><td align="left" valign="bottom">Cat. #41400045</td><td align="left" valign="bottom">Used 1× final concentration</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Insulin (human, recombinant zinc)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #12585014</td><td align="left" valign="bottom">Used 860 nM final concentration</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Percoll</td><td align="left" valign="bottom">GE Healthcare</td><td align="left" valign="bottom">Cat. #17089101</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Protein G Dynabeads</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #10003D</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Complete protease inhibitor cocktail</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat. #11836153001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase CLS3</td><td align="left" valign="bottom">Worthington</td><td align="left" valign="bottom">Cat. #WOLS04180</td><td align="left" valign="bottom">Used 500 U/mL final concentration</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Collagenase CLS4</td><td align="left" valign="bottom">Worthington</td><td align="left" valign="bottom">Cat. #WOLS04186</td><td align="left" valign="bottom">Used 500 U/mL final concentration</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Amyloglucosidase</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat. #11202332001</td><td align="left" valign="bottom">Used 2 mg/mL final concentration</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SuperScript II Reverse Transcriptase</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat. #18064014</td><td align="left" valign="bottom">Used 200 U per reaction</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Micrococcal nuclease</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #88216</td><td align="left" valign="bottom">Used 80 U per reaction</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Protein G Dynabeads</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #10003D</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">Bioconductor</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/">https://www.bioconductor.org/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Trimmomatic</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bolger et al., 2014</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.usadellab.org/cms/">http://www.usadellab.org/cms/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FastQC</td><td align="left" valign="bottom">Babraham Institute</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FASTQ Groomer</td><td align="left" valign="bottom">Galaxy project</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/fastqgroomer/">https://sourceforge.net/projects/fastqgroomer/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Bowtie2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">Langmead and Salzberg, 2012</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/BenLangmead/bowtie2">https://github.com/BenLangmead/bowtie2</ext-link></td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016368">SCR_016368</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BEDtools</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib60">Quinlan and Hall, 2010</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/arq5x/bedtools2">https://github.com/arq5x/bedtools2</ext-link></td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006646">SCR_006646</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Rsubread (featureCounts)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Liao et al., 2014</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://git.bioconductor.org/packages/Rsubread">https://git.bioconductor.org/packages/Rsubread</ext-link></td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_009803">SCR_009803</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MetaCycle</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib84">Wu et al., 2016</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/gangwug/MetaCycleApp">https://github.com/gangwug/MetaCycleApp</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Phase Set Enrichment Analysis</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib89">Zhang et al., 2016</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/ranafi/PSEA">https://github.com/ranafi/PSEA</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MACS2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Feng et al., 2012</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://pypi.org/project/MACS2/">https://pypi.org/project/MACS2/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GREAT</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">McLean et al., 2010</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://great.stanford.edu/public/html/splash.php">http://great.stanford.edu/public/html/splash.php</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FIMO</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Bailey et al., 2015</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://meme-suite.org/tools/fimo">http://meme-suite.org/tools/fimo</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FastHeinz</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Beisser et al., 2010</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/BioNet.html">https://www.bioconductor.org/packages/release/bioc/html/BioNet.html</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">clusterMaker2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib49">Morris et al., 2011</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.rbvi.ucsf.edu/cytoscape/clusterMaker2/">http://www.rbvi.ucsf.edu/cytoscape/clusterMaker2/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Bingo</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib42">Maere et al., 2005</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/cytoscape/BiNGO">https://github.com/cytoscape/BiNGO</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cytoscape</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib72">Shannon et al., 2003</xref></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cytoscape.org/">https://cytoscape.org/</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Qubit fluorometer</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat. #Q33238</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">FreeStyle InsuLinx glucometer</td><td align="left" valign="bottom">Abbott</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Laboratory rodent chow diet</td><td align="left" valign="bottom">Safe diets</td><td align="left" valign="bottom">Cat. #R03-25</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Apistar syrup (organic)</td><td align="left" valign="bottom">ICKO</td><td align="left" valign="bottom">Cat. #HC406</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse models, housing, and diets</title><p>To generate a hepatocyte-specific conditional <italic>Klf10</italic> null allele, mice in the C57BL/6 background and bearing a <italic>Klf10</italic> exon1 flanked by LoxP sites (<italic>Klf10<sup>flox/flox</sup></italic>) described previously (<xref ref-type="bibr" rid="bib83">Weng et al., 2017</xref>) were crossed with a serum albumin-driven <italic>Cre-ER<sup>T2</sup></italic> mouse line (<xref ref-type="bibr" rid="bib71">Schuler et al., 2004</xref>). To obtain mice with a loss of KLF10 in hepatocytes (HepKO), 5-week-old male <italic>Klf10<sup>flox/flox</sup>; Alb<sup>+/CreERT2</sup></italic> mice were gavaged with tamoxifen (10 mg/kg body weight in 200 µl sunflower oil). For all experiments, aged-matched, tamoxifen-treated, <italic>Klf10<sup>flox/flox</sup></italic> male mice were used as wild-type controls (WT). Genotyping was performed by PCR using the primers listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><p>Mice were housed in a temperature- and humidity-controlled room (21°C ± 2°C/70%), maintained on a 12 hr:12 hr LD cycle and fed a standard laboratory chow diet (SafeDiets A03) ad libitum. For the in vivo sugar challenge, mice from each genotype were randomized between the experimental groups and had ad libitum access to standard laboratory chow diet and either water or SSW beverage (water +30% Apistar solution [35% fructose, 33% glucose, 32% sucrose]) for 8 weeks. One animal that did not gain weight after 8 weeks was excluded.</p><p>All animal studies were approved by the local committee for animal ethics Comité Institutionnel d'Éthique Pour l'Animal de Laboratoire (CIEPAL-Azur; authorized protocols: PEA 244 and 557) and conducted in accordance with the CNRS and INSERM institutional guidelines.</p></sec><sec id="s4-2"><title>Primary hepatocyte isolation and culture conditions</title><p>Primary hepatocytes were isolated using a retrograde in situ perfusion procedure as described previously (<xref ref-type="bibr" rid="bib48">Mederacke et al., 2015</xref>) with a few modifications. Briefly, mice were anesthetized between ZT3-ZT6, and upon cannulation via the inferior vena cava, the liver was perfused at a flow rate of 6 mL/min with a warmed (37°C), EGTA solution. After 3 min, the buffer was exchanged for a glucose- and EGTA-free buffer containing 45 mM CaCl<sub>2</sub>, collagenase types CLS3 (500 U/mL) and CLS4 (500 U/mL) (Worthington Biochemical Corporation), and the liver was perfused in this buffer for an additional 5 min at a flow rate of 6 mL/min. After perfusion, the liver was excised and placed in Leibovitz L-15 medium supplemented with 10% fetal calf serum (FCS), 1% penicillin and streptomycin (P/S). Hepatocytes were released by mechanical disruption and filtered through a 70 µm cell strainer and resuspended in 50 mL of Leibovitz L-15, 10% FCS, 1% P/S medium. To seed hepatocytes, the solution was centrifuged at 400 rpm for 2 min and hepatocytes were resuspended in 8 mL William’s E medium supplemented with 860 nM insulin, 1% P/S, 10% FCS, and 1% glutamate. Dead cells were removed by Percoll density-gradient centrifugation. Unless otherwise indicated, hepatocytes were seeded in collagen-coated 6-well plates at a density of 250,000 cells/plate. After hepatocyte attachment, medium was substituted for low-glucose DMEM, supplemented with GlutaMAX, pyruvate, 10 nM dexamethasone (Dex), and 1× insulin-selenium-transferrin (ITS). All hepatocyte manipulations took place the following day, ~12–15 hr after cell attachment.</p></sec><sec id="s4-3"><title>Food-seeking behavioral analysis</title><p>Mice were individually housed with ad libitum access to food and water. An infrared detection system (Actimetrics) was used to assess food seeking behavior. Mice were weighed weekly and their daily food intake was estimated by measuring the difference between the quantity of food provided and food remaining after 1 week. Actogram plots were generated using the ImageJ plugin ‘ActogramJ’ (<xref ref-type="bibr" rid="bib69">Schmid et al., 2011</xref>).</p></sec><sec id="s4-4"><title>Blood analysis</title><p>Unless stated otherwise, all measurements were performed at ZT15. Glycemia levels were measured using a FreeStyle Papillon glucometer (Abbott). Plasma triglycerides were measured using a colorimetric assay kit (Cayman) according to the manufacturer’s protocol. Plasma insulin was measured using a Mouse Insulin Elisa kit (Mercodia) in accordance with the manufacturer’s protocol.</p></sec><sec id="s4-5"><title>Glycogen assay</title><p>Hepatic glycogen was measured as described previously (<xref ref-type="bibr" rid="bib14">Feillet et al., 2016</xref>). Hepatic glycogen was extracted from samples collected at ZT3 and ZT15. Upon precipitation, the glycogen pellet was either resuspended in 2 mg/mL amyloglucosidase (Sigma-Aldrich) or in 0.2 M sodium acetate (pH 4.9) to measure total glucose and free glucose, respectively. Total and free glucose was assayed using a glucose-hexokinase assay kit (Sigma-Aldrich) according to the manufacturer’s protocol.</p></sec><sec id="s4-6"><title>Glucose tolerance test</title><p>Mice were fasted at ZT6 for 6 hr and then injected intraperitoneally with glucose (0.5 g/kg body weight) in 1× PBS. Blood glucose was measured from tail-blood microsamples (&lt;0.5 μL) just before injection and at regular intervals over 2 hr using a FreeStyle Papillon glucometer (Abbott).</p></sec><sec id="s4-7"><title>Liver triglycerides</title><p>Total lipids were extracted from liver samples collected at ZT15 using a modified Folch method (<xref ref-type="bibr" rid="bib16">Folch et al., 1957</xref>). Briefly, 50–100 mg of liver were homogenized in a methanol/chloroform (2:1, v/v) solution. After addition of 1 volume of chloroform and 0.9 volume of water followed by mixing, the organic phase was separated, evaporated, and resuspended in NP40. Triglycerides content was measured using a colorimetric assay kit (Cayman) according to the manufacturer’s protocol.</p></sec><sec id="s4-8"><title>Histology</title><p>Liver tissue was excised, fixed with 4% PFA solution overnight, processed for paraffin embedding, sectioned at 5 μm thickness, and then stained for hematoxylin and eosin (H&amp;E). Liver sections were then imaged using the Vectra Polaris digital slide scanner (CLS143455, Akoya Biosciences Inc) and subjected to blind scoring.</p></sec><sec id="s4-9"><title>Glucose uptake</title><p>Primary hepatocytes from WT and HepKO were seeded in collagen-coated 24-well plates at a density of 150,000 cells per well and incubated overnight in DMEM containing 25 mM glucose, 17 nM ITS, and 10 nM Dex. The following day, cells were washed twice with 1× PBS before stimulation with a glucose-free DMEM containing 17 nM ITS and 1 µM 2-deoxyglucose (2-DG). Hepatocytes were left in this medium for 10 min before the reaction was stopped. Lysates were then assayed for glucose uptake using the Glucose Uptake-Glo Assay kit (Promega) as per the manufacturer’s protocol. Relative light unit (RLU) values were normalized to the total protein concentration of each corresponding sample.</p></sec><sec id="s4-10"><title>Glucose production</title><p>Primary hepatocytes from WT and HepKO were isolated, seeded in collagen-coated 6-well plates at a density of 250,000 cells per well, and incubated overnight in DMEM containing 5 mM glucose, 17 nM ITS, and 10 nM Dex. The following day, the media was removed and hepatocytes were given glucose-free DMEM supplemented with 17 nM ITS and 10 nM Dex, 16 mM lactate, and 4 mM pyruvate. Media (250 µL) was collected 24 hr after replacement. The amount of glucose in each sample was determined using a GOD-PAP colorimetric assay (Randox) as per the manufacturer’s recommendations.</p></sec><sec id="s4-11"><title>Liver extract metabolite identification</title><p>Liver metabolites were extracted following a protocol adapted from <xref ref-type="bibr" rid="bib25">Hui et al., 2017</xref>. Briefly, 10 µL/mg liver of –20°C methanol:acetonitrile:water (40:40:20, v/v/v) solution was added to approximately 50 mg of liver. The mixture was crushed using a pellet pestle for 30 s, followed by sonication for 5 min and vortexing for 15 s. Samples were incubated at 4°C for 10 min to precipitate proteins before centrifugation at 4°C and 15,000 <italic>g</italic> for 10 min. The supernatant was transferred to LC-MS vials for analyses.</p><p>Liver crude organic extracts were analyzed using a Vanquish UHPLC coupled with a Thermo Q-Exactive (Thermo Fisher Scientific GmbH, Bremen, Germany) mass spectrometer (MS) and an ESI source operated with Xcalibur (version 2.2, Thermo Fisher Scientific) software package. Metabolites separation was achieved on a Waters Acquity BEH C8 (1 × 150 mm, 1.7 µm) column with an injection volume of 5 µL and a flow rate of 0.1 mL/min. The mobile phase was composed of octylammonium acetate 4 mM in H<sub>2</sub>O adjusted to pH = 4.6 with acetic acid (phase A) and methanol (phase B) and the following gradient was used: 1% B for 5 min, 1–95% B in 10 min, 95–99% B in 5 min, 99% B held for 3 min, then 1% B for 7 min for a total run time of 30 min. Data acquisition was realized under full scan switch (positive and negative) mode ionization from <italic>m/z</italic> 80–900 at 70,000 resolution followed by inclusion list-dependent MS/MS. Samples were randomized and analyzed in triplicates. A quality control (QC) sample was added by pooling equal volumes of each sample to monitor suitability, repeatability, and stability of the system and injected every 10 samples. An extraction blank sample was also injected every 10 runs in order to monitor sample cross-contamination. Pure commercial standards (fumaric acid, succinic acid, oxaloacetic acid, alpha-ketoglutaric acid, glutamic acid, phosphoenolpyruvic acid, dihydroxy acetone phosphate, citric acid, NADHP, and pyruvic acid, Merck) were analyzed to monitor their retention time, <italic>m/z</italic> of the parent ion and fragment ions. Feature extraction, compound identification, and retention time correction were performed using Compound Discoverer 2.1 software (Thermo Fisher Scientific). Processing of the filtered feature table was realized using Metaboanalyst (<ext-link ext-link-type="uri" xlink:href="http://www.metaboanalyst.ca">http://www.metaboanalyst.ca</ext-link>; <xref ref-type="bibr" rid="bib10">Chong et al., 2019</xref>). Samples were normalized using QCs, data were log transformed then Pareto-scaled (mean-centered and divided by the square root of the standard deviation of each variable). The QCs were then removed from the normalized data table to perform statistical analyses.</p></sec><sec id="s4-12"><title>In vitro stimulation of hepatocytes with glucose and fructose</title><p>After seeding of WT and HepKO hepatocytes, medium was replaced with DMEM supplemented with GlutaMAX, pyruvate, 10 nM Dex, 1× ITS and containing either (1) 5 mM glucose, (2) 25 mM glucose, (3) 5 mM glucose and 5 mM fructose, or (4) 25 mM glucose and 5 mM fructose. After a 12 hr incubation period, media was aspirated and hepatocytes were lysed with Qiagen RLT buffer. Lysed material containing RNA was collected, flash frozen, and stored at –80°C until RNA extraction.</p></sec><sec id="s4-13"><title>RNA isolation and quantitative real-time PCR</title><p>Total RNA was purified using RNeasy extraction mini kit (Qiagen) as per the manufacturer’s instructions. To generate cDNAs, 1 µg of total RNA was reverse transcribed using random hexamer primers and Superscript II reverse transcriptase (Invitrogen). Diluted cDNAs (1/10) were added to a PowerUp SYBR green master mix (Applied Biosystems) and amplified using a StepOnePlus Real-Time PCR system (Applied Biosystems) as per the manufacturer’s instructions. The relative mRNA abundance was calculated using the ΔCt method and normalized to the value of the expression of the housekeeping gene <italic>36B4</italic>. The sequences of primers used are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-14"><title>Western blotting</title><p>Whole-cell extracts from liver tissue or isolated hepatocytes were processed using the Active Motif Nuclear Extraction kit as per the manufacturer’s instructions. Lysates were separated by SDS–PAGE and transferred to PVDF membranes (Bio-Rad). Immunoreactive protein was detected using ECF reagent (Millipore) and Fusion FX7 (Vilber). The primary antibodies used were human anti-KLF10 mAb (1:800) and mouse anti-EGF1a mAb (1:1000). The secondary antibody used was goat anti-mouse IgG (1:40,000).</p></sec><sec id="s4-15"><title>RNA-sequencing</title><p>For the circadian time-course experiment, equal amounts of total RNA extracted from three mouse livers were pooled at each of the eight time points assessed over a 24 hr period. Preparation of libraries and sequencing was performed at UCAGenomiX (Sophia-Antipolis, France). Here, libraries were prepared using the Truseq Stranded Total RNA Preparation Kit with Ribo-Zero Gold (Illumina) following the manufacturer’s recommendations. Normalized libraries were multiplexed, loaded on a flow cell (Illumina), and sequenced on a NextSeq 500 platform (Illumina) using a 2 × 75 bp paired-end (PE) configuration. Image analysis and base calling were conducted by the HiSeq Control Software (HCS). Raw sequencing data (.bcl files) generated from Illumina NextSeq 500 platform was converted into fastq files and de-multiplexed using Illumina’s bcl2fastq 2.17 software.</p><p>For the in vitro sugar challenge experiment, RNA was extracted from WT and HepKO hepatocytes treated with either 5 mM glucose or 25 mM glucose and 5 mM fructose for 12 hr (three biological replicates per experimental condition). Preparation of libraries and sequencing was performed at GENEWIZ (Leipzig, Germany). Here, libraries were prepared using NEBNext Ultra RNA Library Preparation Kit for Illumina (New England Biosystems) following the manufacturer’s recommendations. Normalized libraries were multiplexed, loaded on a flow cell (Illumina), and sequenced on a HiSeq 4000 platform (Illumina) using a 2 × 150 PE configuration. Image analysis and base calling were conducted by the HiSeq Control Software. Raw sequencing data (.bcl files) generated from Illumina HiSeq 4000 platform was converted into fastq files and de-multiplexed using Illumina’s bcl2fastq 2.17 software.</p></sec><sec id="s4-16"><title>Chromatin immunoprecipitation</title><p>Snap frozen liver (~300 mg) was cross-linked with 1.1% formaldehyde in PBS for 20 min at room temperature and cross-linking was quenched with 125 mM glycine for 5 min. After Dounce homogenization, the crushed tissue was washed twice in cold PBS, resuspended in cold cell lysis buffer (50 mM HEPES [pH 8], 200 mM NaCl, 20 mM EDTA, 12% glycerol, 1% NP40, 0.8% Triton-X100, 1 mM PMSF, protease inhibitor cocktail), and sonicated 3× (15 s on/30 s off cycle, low-power mode) in a Bioruptor (Diagenode). Nuclei were purified by sedimentation at 1000 rpm for 5 min, the supernatant was removed, and the pellet was resuspended in nuclei preparation buffer (0.34 M sucrose, 15 mM Tris [pH 8], 15 mM KCl, 0.2 mM EDTA, 0.2 mM EGTA, protease inhibitor cocktail). To digest chromatin, the suspension was incubated with 80 Units micrococcal nuclease (MNase) for 10 min at 37°C. Next, the suspension was spun at 6600 rpm for 5 min, the supernatant was discarded, and nuclei were resuspended in nuclei lysis buffer (50 mM Tris [pH 8], 150 mM NaCl, 10 mM EDTA, 0.5% NP40, 1% Triton-X100, 0.4% SDS, and protease inhibitor cocktail). The sample was sonicated for 12× (30 s on/30 s off, high-power mode) in a bioruptor to release digested chromatin. The suspension containing the fragmented chromatin was centrifuged at 10,000 rpm for 8 min at 4°C to remove debris and the supernatant was diluted in ChIP dilution buffer (50 mM Tris pH 8, 150 mM NaCl, 1% Triton-X100, protease inhibitor cocktail). Protein-DNA complexes were immunoprecipitated using 3–4 µg of human anti-KLF10 mAb (CDI Laboratories) incubated at 4°C overnight and subsequently isolated with protein G Dynabeads for 2 hr at room temperature. Beads were washed four times in low-salt buffer (50 mM Tris [pH 7.4], 5 mM EDTA, 150 mM NaCl, 1% Triton X-100, 0.5% NP40), four times in high-salt wash buffer (100 mM Tris [pH 7.4], 250 mM NaCl, 1% NP40, 1% sodium deoxycholate), once in TE buffer (50 mM Tris [pH 7.4], 10 mM EDTA), and then eluted with 1% SDS-0.1 M NaHCO<sub>3</sub>. Reverse crosslinking of protein-DNA complexes was performed overnight by incubation at 65°C followed by proteinase K digestion for 4 hr at 42°C. DNA fragments were purified using QIAquick PCR purification columns (Qiagen) quantified using a Qubit fluorometer (Invitrogen). Fragmented DNA was flash frozen and stored at –80°C until further processing for high-throughput sequencing or qRT-PCR.</p></sec><sec id="s4-17"><title>ChIP-sequencing</title><p>Preparation of libraries and sequencing was performed at GENEWIZ (Leipzig, Germany). Here, libraries were prepared using NEBNext Ultra DNA Library Preparation Kit for Illumina (New England Biosystems) following the manufacturer’s recommendations. Briefly, the ChIP DNA was end repaired and adapters were ligated after adenylation of the 3′ ends. Adapter-ligated DNA was size selected, followed by clean up, PCR enrichment. ChIP libraries were validated using an Agilent TapeStation and quantified using Qubit 2.0 Fluorometer as well as qRT-PCR (Applied Biosystems, Carlsbad, CA, USA). Normalized libraries were multiplexed, clustered, and loaded on one lane of a flow cell (Illumina). Libraries were sequenced on a HiSeq 4000 platform (Illumina) using a 2 × 150 PE configuration. Image analysis and base calling were conducted by the HiSeq Control Software (HCS). Raw sequence data (.bcl files) generated from Illumina HiSeq was converted into fastq files and de-multiplexed using Illumina’s bcl2fastq 2.17 software. One mismatch was allowed for index sequence identification.</p></sec><sec id="s4-18"><title>Network analysis</title><p>A Network integrating RNA-seq data from the HGF condition of the in vitro sugar challenge experiment and ChIP-seq data was generated using FastHeinz from the R BioNet package (<xref ref-type="bibr" rid="bib4">Beisser et al., 2010</xref>) with the HumanCyc metabolic pathways (<ext-link ext-link-type="uri" xlink:href="http://humancyc.org/">http://humancyc.org/</ext-link>) downloaded from <ext-link ext-link-type="uri" xlink:href="http://www.ndexbio.org">http://www.ndexbio.org</ext-link> (<xref ref-type="bibr" rid="bib57">Pillich et al., 2017</xref>). Next, a weight matrix was constructed with all expressed genes in the WT and HepKO primary hepatocytes taking the lowest p-value from the ChIP-seq RNA-seq datasets. Network visualization was done using Cytoscape and AutoAnnotate app (<xref ref-type="bibr" rid="bib34">Kucera et al., 2016</xref>; <xref ref-type="bibr" rid="bib72">Shannon et al., 2003</xref>). Clustering was performed using the MCL partitioning algorithm from clusterMaker2 (<xref ref-type="bibr" rid="bib49">Morris et al., 2011</xref>), and gene ontology analysis was performed using BiNGO (<xref ref-type="bibr" rid="bib42">Maere et al., 2005</xref>) at <ext-link ext-link-type="uri" xlink:href="http://impala.molgen.mpg.de/">http://impala.molgen.mpg.de/</ext-link> (<xref ref-type="bibr" rid="bib30">Kamburov et al., 2011</xref>) and at <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/">https://www.uniprot.org/</ext-link>.</p></sec><sec id="s4-19"><title>Alignment, quantification, and statistical analyses</title><p>For the circadian time-course experiment, sequences were preprocessed using FASTQ Groomer and checked using FastQC (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Reads were mapped against the <italic>Mus musculus</italic> genome (mm10) downloaded from <ext-link ext-link-type="uri" xlink:href="http://ensembl.org/">Ensembl.org</ext-link> using STAR_2.4.0a (<xref ref-type="bibr" rid="bib11">Dobin et al., 2013</xref>) with the Encode RNA-seq best practices options indicated (“–outFilterIntronMotifsRemoveNoncanonicalUnannotated –alignMatesGapMax 1000000 –outReadsUnmapped Fastx –alignIntronMin 20 –alignIntronMax 1000000 –alignSJoverhangMin 8 –alignSJDBoverhangMin 1 –outFilterMultimapNmax 20”). After alignment to the genome reads were counted with featureCounts (<xref ref-type="bibr" rid="bib40">Liao et al., 2014</xref>) with “–primary –g gene_name –p –s 1 –M –C” options indicated. Gene stable IDs (GRCm38.p6) were downloaded from Ensembl Genes 94 (Ensembl) and used to filter for mouse protein coding genes. Matrix of raw counts from both genotypes across time was generated in R. Transcripts with less than eight counts across all samples were excluded from downstream analyses. All transcript counts were normalized using edgeR (<xref ref-type="bibr" rid="bib63">Robinson et al., 2010</xref>) and expressed in counts per million (cpm).</p><p>Circadian expression of mRNA was determined using MetaCycle (<xref ref-type="bibr" rid="bib84">Wu et al., 2016</xref>) with the following options: minper = 24, maxper = 24, cycMethod = c (“ARS,” “JTK,” “LS”), analysisStrategy = “auto,” outputFile = TRUE, outIntegration = “both,” adjustPhase = “predictedPer,” combinePvalue = “fisher,” weightedPerPha = TRUE, ARSmle = “auto,” and ARSdefaultPer = 24. Transcripts with an integrated p-value (meta2d_pvalue) &lt; 0.05 were considered rhythmically expressed.</p><p>Circadian pathways were determined by PSEA (<xref ref-type="bibr" rid="bib89">Zhang et al., 2016</xref>) based on the sets of circadian transcripts with a relative amplitude value (rAMP; the ratio between amplitude and baseline expression) of ≥0.1. Gene sets were downloaded from the Molecular Signatures database (MSigDB) H (HallmarkGene Sets; <xref ref-type="bibr" rid="bib77">Subramanian et al., 2005</xref>). Sets containing fewer than five circadian transcripts were excluded from the analysis. The Kuiper test was used to identify circadian gene sets by comparing the acrophases of all circadian transcripts belonging to each gene set to a uniform background distribution and by testing for non-uniformity (q &lt; 0.01).</p><p>For the in vitro sugar challenge experiment, sequences were preprocessed using FASTQ Groomer and checked using FastQC (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Reads were mapped against the <italic>M. musculus</italic> genome (mm10) downloaded from <ext-link ext-link-type="uri" xlink:href="http://ensembl.org/">Ensembl.org</ext-link> using HISAT2with default parameters (<xref ref-type="bibr" rid="bib32">Kim et al., 2015</xref>). After alignment to the genome, reads were counted with featureCounts (<xref ref-type="bibr" rid="bib40">Liao et al., 2014</xref>) with default parameters. Matrices containing the counts were loaded into R. For downstream analyses, we analyzed protein coding genes with a sum &gt;20 counts across all samples. Differential expression analysis between conditions was performed using the TestDE function in the R package ‘edgeR’ (<xref ref-type="bibr" rid="bib63">Robinson et al., 2010</xref>). Genes with an FDR value &lt;0.05 when comparing LG vs. HGF conditions in each respective genotype were considered differentially expressed and were subsequently used to assess the pathways enriched under the LG and HGF conditions. Gene lists were uploaded to enrichR web server (<xref ref-type="bibr" rid="bib9">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Kuleshov et al., 2016</xref>), and pathway enrichment was assessed by comparing the overlap of genes in the query to the Kyoto Encyclopedia of Genes and Genomes (KEGG) 2019 mouse gene sets (<xref ref-type="bibr" rid="bib31">Kanehisa and Goto, 2000</xref>).</p><p>For ChIP-seq read mapping, peak calling, and quantification, sequences were first preprocessed using FASTQ Groomer and checked using FastQC (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). PE reads were trimmed to 50 bases with Trimmomatic (<xref ref-type="bibr" rid="bib5">Bolger et al., 2014</xref>), and reads were aligned to mouse genome (GRCm38/mm10) using Bowtie2 (<xref ref-type="bibr" rid="bib37">Langmead and Salzberg, 2012</xref>) with the default parameters. Next, peak calls were made in MACS2 (<xref ref-type="bibr" rid="bib15">Feng et al., 2012</xref>) with default parameters, except allowing for duplicates. Filters were applied to keep peaks with a log p-value &lt;–2 and an Mfold &gt;2. Results from the independent ChIP-seq runs were concatenated and intervals were merged using the MergeBED function from BEDtools (<xref ref-type="bibr" rid="bib60">Quinlan and Hall, 2010</xref>). Identified peaks within the –10 kb to +1 kb region relative to the TSS were annotated using GREAT (<xref ref-type="bibr" rid="bib47">McLean et al., 2010</xref>) and further filtered for the presence of a KLF10 motif (matrix ID: MA1511.1, <ext-link ext-link-type="uri" xlink:href="http://jaspar.genereg.net/">http://jaspar.genereg.net/</ext-link>) using FIMO (<xref ref-type="bibr" rid="bib1">Bailey et al., 2015</xref>).</p><p>All numerical values are presented as mean ± SEM. Replicates (n) are indicated in the figure legends. Pairwise comparisons were tested using the nonparametric Wilcoxon test. Differences between more than two experimental conditions were tested using the Kruskal–Wallis rank sum test for multiple comparison followed by a pairwise <italic>post-ho</italic>c test using the Benjamini–Hochberg adjustment. In <xref ref-type="fig" rid="fig4">Figure 4I</xref>, a three-way ANOVA was performed. p-values less than 0.05 were considered significant.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>none</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology, Resources</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology, Resources</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Funding acquisition, Methodology, Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing - original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal studies were approved by the local committee for animal ethics Comité Institutionnel d'Éthique Pour l'Animal de Laboratoire (CIEPAL-Azur; Authorized protocols: PEA 244 and 557) and conducted in accordance with the CNRS and INSERM institutional guidelines.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers used in the study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65574-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-65574-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in European Nucleotide Archive under accession codes PRJEB39035, PRJEB39036, PRJEB40195. All data generated or analysed during this study are included in the manuscript and in source data files provided for Figures 1-7.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ruberto</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Genome-wide profiling of KLF10 binding loci in mouse liver</data-title><source>EBI</source><pub-id pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB40195">PRJEB40195</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ruberto</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Transcriptional response of hepatocytes lacking KLF10 to a high sugar challenge</data-title><source>EBI</source><pub-id pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB39036">PRJEB39036</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ruberto</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Circadian profiling of livers from control and hepatocyte-specific KLF10 knockout mice using RNA seq</data-title><source>EBI</source><pub-id pub-id-type="accession" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB39035">PRJEB39035</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This study was supported by French Agence Nationale pour la Recherche (ANR): #ANR-12-BSV1-0014 and by the &quot;Investments for the Future&quot; LABEX SIGNALIFE (#ANR-11-LABX-0028-01), the UCA<sup>JEDI</sup> Investments in the Future project (#ANR-15-IDEX-01) and ATER grant from Université Côte d’Azur (JSR). We thank the Canceropôle Provence-Alpes-Côte d’Azur and the Provence-Alpes-Côte d’Azur Region for the financial support provided to the MetaboCell project. We thank Pierre Chambon for the gift of <italic>Alb-CreER<sup>T2</sup></italic> mice. We thank Aurélie Biancardini, Angelo Barnabeo, Pierre Chérel, Antoine Landouar, and the staff of the mouse facility for assistance with the animal care. We thank Sama Rekami for the help with the histopathology and the PFTC facility for technical support.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>TL</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Grant</surname><given-names>CE</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The MEME Suite</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W39</fpage><lpage>W49</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv416</pub-id><pub-id pub-id-type="pmid">25953851</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartok</surname><given-names>O</given-names></name><name><surname>Teesalu</surname><given-names>M</given-names></name><name><surname>Ashwall-Fluss</surname><given-names>R</given-names></name><name><surname>Pandey</surname><given-names>V</given-names></name><name><surname>Hanan</surname><given-names>M</given-names></name><name><surname>Rovenko</surname><given-names>BM</given-names></name><name><surname>Poukkula</surname><given-names>M</given-names></name><name><surname>Havula</surname><given-names>E</given-names></name><name><surname>Moussaieff</surname><given-names>A</given-names></name><name><surname>Vodala</surname><given-names>S</given-names></name><name><surname>Nahmias</surname><given-names>Y</given-names></name><name><surname>Kadener</surname><given-names>S</given-names></name><name><surname>Hietakangas</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The transcription factor Cabut coordinates energy metabolism and the circadian clock in response to sugar sensing</article-title><source>The EMBO Journal</source><volume>34</volume><fpage>1538</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.15252/embj.201591385</pub-id><pub-id pub-id-type="pmid">25916830</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bass</surname><given-names>J</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circadian time signatures of fitness and disease</article-title><source>Science</source><volume>354</volume><fpage>994</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1126/science.aah4965</pub-id><pub-id pub-id-type="pmid">27885004</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beisser</surname><given-names>D</given-names></name><name><surname>Klau</surname><given-names>GW</given-names></name><name><surname>Dandekar</surname><given-names>T</given-names></name><name><surname>Müller</surname><given-names>T</given-names></name><name><surname>Dittrich</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BioNet: an R-Package for the functional analysis of biological networks</article-title><source>Bioinformatics</source><volume>26</volume><fpage>1129</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq089</pub-id><pub-id pub-id-type="pmid">20189939</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname><given-names>AM</given-names></name><name><surname>Lohse</surname><given-names>M</given-names></name><name><surname>Usadel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title><source>Bioinformatics</source><volume>30</volume><fpage>2114</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugge</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Everett</surname><given-names>LJ</given-names></name><name><surname>Briggs</surname><given-names>ER</given-names></name><name><surname>Mullican</surname><given-names>SE</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Jager</surname><given-names>J</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>657</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1101/gad.186858.112</pub-id><pub-id pub-id-type="pmid">22474260</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cederroth</surname><given-names>CR</given-names></name><name><surname>Albrecht</surname><given-names>U</given-names></name><name><surname>Bass</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>SA</given-names></name><name><surname>Dyhrfjeld-Johnsen</surname><given-names>J</given-names></name><name><surname>Gachon</surname><given-names>F</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name><name><surname>Hastings</surname><given-names>MH</given-names></name><name><surname>Helfrich-Förster</surname><given-names>C</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name><name><surname>Lévi</surname><given-names>F</given-names></name><name><surname>Loudon</surname><given-names>A</given-names></name><name><surname>Lundkvist</surname><given-names>GB</given-names></name><name><surname>Meijer</surname><given-names>JH</given-names></name><name><surname>Rosbash</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>JS</given-names></name><name><surname>Young</surname><given-names>M</given-names></name><name><surname>Canlon</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Medicine in the Fourth Dimension</article-title><source>Cell Metabolism</source><volume>30</volume><fpage>238</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2019.06.019</pub-id><pub-id pub-id-type="pmid">31390550</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceglia</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Agostinelli</surname><given-names>F</given-names></name><name><surname>Eckel-Mahan</surname><given-names>K</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CircadiOmics: circadian omic web portal</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>W157</fpage><lpage>W162</lpage><pub-id pub-id-type="doi">10.1093/nar/gky441</pub-id><pub-id pub-id-type="pmid">29912458</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>EY</given-names></name><name><surname>Tan</surname><given-names>CM</given-names></name><name><surname>Kou</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Meirelles</surname><given-names>GV</given-names></name><name><surname>Clark</surname><given-names>NR</given-names></name><name><surname>Ma’ayan</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool</article-title><source>BMC Bioinformatics</source><volume>14</volume><elocation-id>128</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id><pub-id pub-id-type="pmid">23586463</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>J</given-names></name><name><surname>Wishart</surname><given-names>DS</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis</article-title><source>Current Protocols in Bioinformatics</source><volume>68</volume><elocation-id>e86</elocation-id><pub-id pub-id-type="doi">10.1002/cpbi.86</pub-id><pub-id pub-id-type="pmid">31756036</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyar</surname><given-names>KA</given-names></name><name><surname>Lutter</surname><given-names>D</given-names></name><name><surname>Artati</surname><given-names>A</given-names></name><name><surname>Ceglia</surname><given-names>NJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Armenta</surname><given-names>D</given-names></name><name><surname>Jastroch</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>S</given-names></name><name><surname>de Mateo</surname><given-names>S</given-names></name><name><surname>Cervantes</surname><given-names>M</given-names></name><name><surname>Abbondante</surname><given-names>S</given-names></name><name><surname>Tognini</surname><given-names>P</given-names></name><name><surname>Orozco-Solis</surname><given-names>R</given-names></name><name><surname>Kinouchi</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Swerdloff</surname><given-names>R</given-names></name><name><surname>Nadeef</surname><given-names>S</given-names></name><name><surname>Masri</surname><given-names>S</given-names></name><name><surname>Magistretti</surname><given-names>P</given-names></name><name><surname>Orlando</surname><given-names>V</given-names></name><name><surname>Borrelli</surname><given-names>E</given-names></name><name><surname>Uhlenhaut</surname><given-names>NH</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Adamski</surname><given-names>J</given-names></name><name><surname>Tschöp</surname><given-names>MH</given-names></name><name><surname>Eckel-Mahan</surname><given-names>K</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Atlas of Circadian Metabolism Reveals System-wide Coordination and Communication between Clocks</article-title><source>Cell</source><volume>174</volume><fpage>1571</fpage><lpage>1585</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.08.042</pub-id><pub-id pub-id-type="pmid">30193114</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckel-Mahan</surname><given-names>KL</given-names></name><name><surname>Patel</surname><given-names>VR</given-names></name><name><surname>de Mateo</surname><given-names>S</given-names></name><name><surname>Orozco-Solis</surname><given-names>R</given-names></name><name><surname>Ceglia</surname><given-names>NJ</given-names></name><name><surname>Sahar</surname><given-names>S</given-names></name><name><surname>Dilag-Penilla</surname><given-names>SA</given-names></name><name><surname>Dyar</surname><given-names>KA</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Reprogramming of the circadian clock by nutritional challenge</article-title><source>Cell</source><volume>155</volume><fpage>1464</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.11.034</pub-id><pub-id pub-id-type="pmid">24360271</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feillet</surname><given-names>C</given-names></name><name><surname>Guérin</surname><given-names>S</given-names></name><name><surname>Lonchampt</surname><given-names>M</given-names></name><name><surname>Dacquet</surname><given-names>C</given-names></name><name><surname>Gustafsson</surname><given-names>J-Å</given-names></name><name><surname>Delaunay</surname><given-names>F</given-names></name><name><surname>Teboul</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sexual Dimorphism in Circadian Physiology Is Altered in LXRα Deficient Mice</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0150665</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0150665</pub-id><pub-id pub-id-type="pmid">26938655</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Qin</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identifying ChIP-seq enrichment using MACS</article-title><source>Nature Protocols</source><volume>7</volume><fpage>1728</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1038/nprot.2012.101</pub-id><pub-id pub-id-type="pmid">22936215</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folch</surname><given-names>J</given-names></name><name><surname>Lees</surname><given-names>M</given-names></name><name><surname>Sloane stanley</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="1957">1957</year><article-title>A simple method for the isolation and purification of total lipides from animal tissues</article-title><source>The Journal of Biological Chemistry</source><volume>226</volume><fpage>497</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)64849-5</pub-id><pub-id pub-id-type="pmid">13428781</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaucher</surname><given-names>J</given-names></name><name><surname>Kinouchi</surname><given-names>K</given-names></name><name><surname>Ceglia</surname><given-names>N</given-names></name><name><surname>Montellier</surname><given-names>E</given-names></name><name><surname>Peleg</surname><given-names>S</given-names></name><name><surname>Greco</surname><given-names>CM</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Forne</surname><given-names>I</given-names></name><name><surname>Masri</surname><given-names>S</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Imhof</surname><given-names>A</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct metabolic adaptation of liver circadian pathways to acute and chronic patterns of alcohol intake</article-title><source>PNAS</source><volume>116</volume><fpage>25250</fpage><lpage>25259</lpage><pub-id pub-id-type="doi">10.1073/pnas.1911189116</pub-id><pub-id pub-id-type="pmid">31757851</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwell</surname><given-names>BJ</given-names></name><name><surname>Trott</surname><given-names>AJ</given-names></name><name><surname>Beytebiere</surname><given-names>JR</given-names></name><name><surname>Pao</surname><given-names>S</given-names></name><name><surname>Bosley</surname><given-names>A</given-names></name><name><surname>Beach</surname><given-names>E</given-names></name><name><surname>Finegan</surname><given-names>P</given-names></name><name><surname>Hernandez</surname><given-names>C</given-names></name><name><surname>Menet</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rhythmic Food Intake Drives Rhythmic Gene Expression More Potently than the Hepatic Circadian Clock in Mice</article-title><source>Cell Reports</source><volume>27</volume><fpage>649</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.064</pub-id><pub-id pub-id-type="pmid">30995463</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillaumond</surname><given-names>F</given-names></name><name><surname>Gréchez-Cassiau</surname><given-names>A</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Brangolo</surname><given-names>S</given-names></name><name><surname>Peteri-Brünback</surname><given-names>B</given-names></name><name><surname>Staels</surname><given-names>B</given-names></name><name><surname>Fiévet</surname><given-names>C</given-names></name><name><surname>Spelsberg</surname><given-names>TC</given-names></name><name><surname>Delaunay</surname><given-names>F</given-names></name><name><surname>Teboul</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>3059</fpage><lpage>3070</lpage><pub-id pub-id-type="doi">10.1128/MCB.01141-09</pub-id><pub-id pub-id-type="pmid">20385766</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>SS</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Sangwung</surname><given-names>P</given-names></name><name><surname>Tugal</surname><given-names>D</given-names></name><name><surname>Atkins</surname><given-names>GB</given-names></name><name><surname>Prosdocimo</surname><given-names>DA</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Tso</surname><given-names>P</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Jain</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Circadian control of bile acid synthesis by a KLF15-Fgf15 axis</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7231</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8231</pub-id><pub-id pub-id-type="pmid">26040986</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannou</surname><given-names>SA</given-names></name><name><surname>Haslam</surname><given-names>DE</given-names></name><name><surname>McKeown</surname><given-names>NM</given-names></name><name><surname>Herman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fructose metabolism and metabolic disease</article-title><source>The Journal of Clinical Investigation</source><volume>128</volume><fpage>545</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1172/JCI96702</pub-id><pub-id pub-id-type="pmid">29388924</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>T</given-names></name><name><surname>Okano</surname><given-names>T</given-names></name><name><surname>Kokame</surname><given-names>K</given-names></name><name><surname>Shirotani-Ikejima</surname><given-names>H</given-names></name><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Fukada</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts</article-title><source>The Journal of Biological Chemistry</source><volume>277</volume><fpage>44244</fpage><lpage>44251</lpage><pub-id pub-id-type="doi">10.1074/jbc.M206233200</pub-id><pub-id pub-id-type="pmid">12213820</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>PN</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Sweet</surname><given-names>DR</given-names></name><name><surname>Jain</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Krüppel-Like Factors and Control of Energy Homeostasis</article-title><source>Endocrine Reviews</source><volume>40</volume><fpage>137</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1210/er.2018-00151</pub-id><pub-id pub-id-type="pmid">30307551</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>LT</given-names></name><name><surname>Chang</surname><given-names>HW</given-names></name><name><surname>Wu</surname><given-names>MJ</given-names></name><name><surname>Lai</surname><given-names>YT</given-names></name><name><surname>Wu</surname><given-names>WC</given-names></name><name><surname>Yu</surname><given-names>WCY</given-names></name><name><surname>Chang</surname><given-names>VHS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Klf10 deficiency in mice exacerbates pulmonary inflammation by increasing expression of the proinflammatory molecule NPRA</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>79</volume><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2016.08.027</pub-id><pub-id pub-id-type="pmid">27592451</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>S</given-names></name><name><surname>Ghergurovich</surname><given-names>JM</given-names></name><name><surname>Morscher</surname><given-names>RJ</given-names></name><name><surname>Jang</surname><given-names>C</given-names></name><name><surname>Teng</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Esparza</surname><given-names>LA</given-names></name><name><surname>Reya</surname><given-names>T</given-names></name><name><surname>Yanxiang</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>E</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Glucose feeds the TCA cycle via circulating lactate</article-title><source>Nature</source><volume>551</volume><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1038/nature24057</pub-id><pub-id pub-id-type="pmid">29045397</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iizuka</surname><given-names>K</given-names></name><name><surname>Takeda</surname><given-names>J</given-names></name><name><surname>Horikawa</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Krüppel-like factor-10 is directly regulated by carbohydrate response element-binding protein in rat primary hepatocytes</article-title><source>Biochemical and Biophysical Research Communications</source><volume>412</volume><fpage>638</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.08.016</pub-id><pub-id pub-id-type="pmid">21856285</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobi</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Burkewitz</surname><given-names>K</given-names></name><name><surname>Kory</surname><given-names>N</given-names></name><name><surname>Knudsen</surname><given-names>NH</given-names></name><name><surname>Alexander</surname><given-names>RK</given-names></name><name><surname>Unluturk</surname><given-names>U</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Hyde</surname><given-names>AL</given-names></name><name><surname>Gangl</surname><given-names>MR</given-names></name><name><surname>Mair</surname><given-names>WB</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>709</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.08.006</pub-id><pub-id pub-id-type="pmid">26365180</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>T</given-names></name><name><surname>Abdelmalek</surname><given-names>MF</given-names></name><name><surname>Sullivan</surname><given-names>S</given-names></name><name><surname>Nadeau</surname><given-names>KJ</given-names></name><name><surname>Green</surname><given-names>M</given-names></name><name><surname>Roncal</surname><given-names>C</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Kuwabara</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>DH</given-names></name><name><surname>Tolan</surname><given-names>DR</given-names></name><name><surname>Sanchez-Lozada</surname><given-names>LG</given-names></name><name><surname>Rosen</surname><given-names>HR</given-names></name><name><surname>Lanaspa</surname><given-names>MA</given-names></name><name><surname>Diehl</surname><given-names>AM</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fructose and sugar: A major mediator of non-alcoholic fatty liver disease</article-title><source>Journal of Hepatology</source><volume>68</volume><fpage>1063</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.01.019</pub-id><pub-id pub-id-type="pmid">29408694</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeyaraj</surname><given-names>D</given-names></name><name><surname>Scheer</surname><given-names>F</given-names></name><name><surname>Ripperger</surname><given-names>JA</given-names></name><name><surname>Haldar</surname><given-names>SM</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Prosdocimo</surname><given-names>DA</given-names></name><name><surname>Eapen</surname><given-names>SJ</given-names></name><name><surname>Eapen</surname><given-names>BL</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Mahabeleshwar</surname><given-names>GH</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Casadesus</surname><given-names>G</given-names></name><name><surname>Mintz</surname><given-names>EM</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Bass</surname><given-names>J</given-names></name><name><surname>Shea</surname><given-names>SA</given-names></name><name><surname>Albrecht</surname><given-names>U</given-names></name><name><surname>Jain</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Klf15 orchestrates circadian nitrogen homeostasis</article-title><source>Cell Metabolism</source><volume>15</volume><fpage>311</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.01.020</pub-id><pub-id pub-id-type="pmid">22405069</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamburov</surname><given-names>A</given-names></name><name><surname>Pentchev</surname><given-names>K</given-names></name><name><surname>Galicka</surname><given-names>H</given-names></name><name><surname>Wierling</surname><given-names>C</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Herwig</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ConsensusPathDB: toward a more complete picture of cell biology</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>D712</fpage><lpage>D717</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1156</pub-id><pub-id pub-id-type="pmid">21071422</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title><source>Nucleic Acids Research</source><volume>28</volume><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="pmid">10592173</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HISAT: a fast spliced aligner with low memory requirements</article-title><source>Nature Methods</source><volume>12</volume><fpage>357</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id><pub-id pub-id-type="pmid">25751142</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klip</surname><given-names>A</given-names></name><name><surname>McGraw</surname><given-names>TE</given-names></name><name><surname>James</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Thirty sweet years of GLUT4</article-title><source>The Journal of Biological Chemistry</source><volume>294</volume><fpage>11369</fpage><lpage>11381</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV119.008351</pub-id><pub-id pub-id-type="pmid">31175156</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucera</surname><given-names>M</given-names></name><name><surname>Isserlin</surname><given-names>R</given-names></name><name><surname>Arkhangorodsky</surname><given-names>A</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>AutoAnnotate: A Cytoscape app for summarizing networks with semantic annotations</article-title><source>F1000Research</source><volume>5</volume><elocation-id>1717</elocation-id><pub-id pub-id-type="doi">10.12688/f1000research.9090.1</pub-id><pub-id pub-id-type="pmid">27830058</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname><given-names>MV</given-names></name><name><surname>Jones</surname><given-names>MR</given-names></name><name><surname>Rouillard</surname><given-names>AD</given-names></name><name><surname>Fernandez</surname><given-names>NF</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Koplev</surname><given-names>S</given-names></name><name><surname>Jenkins</surname><given-names>SL</given-names></name><name><surname>Jagodnik</surname><given-names>KM</given-names></name><name><surname>Lachmann</surname><given-names>A</given-names></name><name><surname>McDermott</surname><given-names>MG</given-names></name><name><surname>Monteiro</surname><given-names>CD</given-names></name><name><surname>Gundersen</surname><given-names>GW</given-names></name><name><surname>Ma’ayan</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W90</fpage><lpage>W97</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id><pub-id pub-id-type="pmid">27141961</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>la Fleur</surname><given-names>SE</given-names></name><name><surname>Kalsbeek</surname><given-names>A</given-names></name><name><surname>Wortel</surname><given-names>J</given-names></name><name><surname>Fekkes</surname><given-names>ML</given-names></name><name><surname>Buijs</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A daily rhythm in glucose tolerance: a role for the suprachiasmatic nucleus</article-title><source>Diabetes</source><volume>50</volume><fpage>1237</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.2337/diabetes.50.6.1237</pub-id><pub-id pub-id-type="pmid">11375322</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leclère</surname><given-names>PS</given-names></name><name><surname>Rousseau</surname><given-names>D</given-names></name><name><surname>Patouraux</surname><given-names>S</given-names></name><name><surname>Guérin</surname><given-names>S</given-names></name><name><surname>Bonnafous</surname><given-names>S</given-names></name><name><surname>Gréchez-Cassiau</surname><given-names>A</given-names></name><name><surname>Ruberto</surname><given-names>AA</given-names></name><name><surname>Luci</surname><given-names>C</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>A</given-names></name><name><surname>Delaunay</surname><given-names>F</given-names></name><name><surname>Gual</surname><given-names>P</given-names></name><name><surname>Teboul</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>MCD diet-induced steatohepatitis generates a diurnal rhythm of associated biomarkers and worsens liver injury in Klf10 deficient mice</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>12139</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-69085-w</pub-id><pub-id pub-id-type="pmid">32699233</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Oh</surname><given-names>AR</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><name><surname>Moon</surname><given-names>YA</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Cha</surname><given-names>JY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>E331</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22010331</pub-id><pub-id pub-id-type="pmid">33396939</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>LN</given-names></name><name><surname>Towle</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>28721</fpage><lpage>28730</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601576200</pub-id><pub-id pub-id-type="pmid">16885160</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maere</surname><given-names>S</given-names></name><name><surname>Heymans</surname><given-names>K</given-names></name><name><surname>Kuiper</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks</article-title><source>Bioinformatics</source><volume>21</volume><fpage>3448</fpage><lpage>3449</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti551</pub-id><pub-id pub-id-type="pmid">15972284</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makwana</surname><given-names>K</given-names></name><name><surname>Gosai</surname><given-names>N</given-names></name><name><surname>Poe</surname><given-names>A</given-names></name><name><surname>Kondratov</surname><given-names>RV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Calorie restriction reprograms diurnal rhythms in protein translation to regulate metabolism</article-title><source>FASEB Journal</source><volume>33</volume><fpage>4473</fpage><lpage>4489</lpage><pub-id pub-id-type="doi">10.1096/fj.201802167R</pub-id><pub-id pub-id-type="pmid">30566374</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masri</surname><given-names>S</given-names></name><name><surname>Papagiannakopoulos</surname><given-names>T</given-names></name><name><surname>Kinouchi</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cervantes</surname><given-names>M</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Jacks</surname><given-names>T</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis</article-title><source>Cell</source><volume>165</volume><fpage>896</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.039</pub-id><pub-id pub-id-type="pmid">27153497</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauvoisin</surname><given-names>D</given-names></name><name><surname>Gachon</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proteomics in circadian biology</article-title><source>Journal of Molecular Biology</source><volume>432</volume><fpage>3565</fpage><lpage>3577</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.12.004</pub-id><pub-id pub-id-type="pmid">31843517</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzoccoli</surname><given-names>G</given-names></name><name><surname>De Cosmo</surname><given-names>S</given-names></name><name><surname>Mazza</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>193</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00193</pub-id><pub-id pub-id-type="pmid">29662454</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>CY</given-names></name><name><surname>Bristor</surname><given-names>D</given-names></name><name><surname>Hiller</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>SL</given-names></name><name><surname>Schaar</surname><given-names>BT</given-names></name><name><surname>Lowe</surname><given-names>CB</given-names></name><name><surname>Wenger</surname><given-names>AM</given-names></name><name><surname>Bejerano</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title><source>Nature Biotechnology</source><volume>28</volume><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1038/nbt.1630</pub-id><pub-id pub-id-type="pmid">20436461</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mederacke</surname><given-names>I</given-names></name><name><surname>Dapito</surname><given-names>DH</given-names></name><name><surname>Affò</surname><given-names>S</given-names></name><name><surname>Uchinami</surname><given-names>H</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers</article-title><source>Nature Protocols</source><volume>10</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.017</pub-id><pub-id pub-id-type="pmid">25612230</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Apeltsin</surname><given-names>L</given-names></name><name><surname>Newman</surname><given-names>AM</given-names></name><name><surname>Baumbach</surname><given-names>J</given-names></name><name><surname>Wittkop</surname><given-names>T</given-names></name><name><surname>Su</surname><given-names>G</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>clusterMaker: a multi-algorithm clustering plugin for Cytoscape</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>436</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-436</pub-id><pub-id pub-id-type="pmid">22070249</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortera</surname><given-names>RR</given-names></name><name><surname>Bains</surname><given-names>Y</given-names></name><name><surname>Gugliucci</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fructose at the crossroads of the metabolic syndrome and obesity epidemics</article-title><source>Frontiers in Bioscience</source><volume>24</volume><fpage>186</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.2741/4713</pub-id><pub-id pub-id-type="pmid">30468651</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherji</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>SM</given-names></name><name><surname>Staels</surname><given-names>B</given-names></name><name><surname>Baumert</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The circadian clock and liver function in health and disease</article-title><source>Journal of Hepatology</source><volume>71</volume><fpage>200</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2019.03.020</pub-id><pub-id pub-id-type="pmid">30930223</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oishi</surname><given-names>Y</given-names></name><name><surname>Manabe</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>5</volume><elocation-id>69</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2018.00069</pub-id><pub-id pub-id-type="pmid">29942807</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Prieto</surname><given-names>P</given-names></name><name><surname>Postic</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Carbohydrate Sensing Through the Transcription Factor ChREBP</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>472</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00472</pub-id><pub-id pub-id-type="pmid">31275349</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circadian physiology of metabolism</article-title><source>Science</source><volume>354</volume><fpage>1008</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1126/science.aah4967</pub-id><pub-id pub-id-type="pmid">27885007</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peek</surname><given-names>CB</given-names></name><name><surname>Affinati</surname><given-names>AH</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Kuo</surname><given-names>HY</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Sena</surname><given-names>LA</given-names></name><name><surname>Ilkayeva</surname><given-names>O</given-names></name><name><surname>Marcheva</surname><given-names>B</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Omura</surname><given-names>C</given-names></name><name><surname>Levine</surname><given-names>DC</given-names></name><name><surname>Bacsik</surname><given-names>DJ</given-names></name><name><surname>Gius</surname><given-names>D</given-names></name><name><surname>Newgard</surname><given-names>CB</given-names></name><name><surname>Goetzman</surname><given-names>E</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Denu</surname><given-names>JM</given-names></name><name><surname>Mrksich</surname><given-names>M</given-names></name><name><surname>Bass</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice</article-title><source>Science</source><volume>342</volume><elocation-id>1243417</elocation-id><pub-id pub-id-type="doi">10.1126/science.1243417</pub-id><pub-id pub-id-type="pmid">24051248</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perelis</surname><given-names>M</given-names></name><name><surname>Marcheva</surname><given-names>B</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Schipma</surname><given-names>MJ</given-names></name><name><surname>Hutchison</surname><given-names>AL</given-names></name><name><surname>Taguchi</surname><given-names>A</given-names></name><name><surname>Peek</surname><given-names>CB</given-names></name><name><surname>Hong</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Omura</surname><given-names>C</given-names></name><name><surname>Allred</surname><given-names>AL</given-names></name><name><surname>Bradfield</surname><given-names>CA</given-names></name><name><surname>Dinner</surname><given-names>AR</given-names></name><name><surname>Barish</surname><given-names>GD</given-names></name><name><surname>Bass</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion</article-title><source>Science</source><volume>350</volume><elocation-id>aac4250</elocation-id><pub-id pub-id-type="doi">10.1126/science.aac4250</pub-id><pub-id pub-id-type="pmid">26542580</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillich</surname><given-names>RT</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Rynkov</surname><given-names>V</given-names></name><name><surname>Welker</surname><given-names>D</given-names></name><name><surname>Pratt</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>NDEx: A Community Resource for Sharing and Publishing of Biological Networks</article-title><source>Methods in Molecular Biology</source><volume>1558</volume><fpage>271</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6783-4_13</pub-id><pub-id pub-id-type="pmid">28150243</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poolman</surname><given-names>TM</given-names></name><name><surname>Gibbs</surname><given-names>J</given-names></name><name><surname>Walker</surname><given-names>AL</given-names></name><name><surname>Dickson</surname><given-names>S</given-names></name><name><surname>Farrell</surname><given-names>L</given-names></name><name><surname>Hensman</surname><given-names>J</given-names></name><name><surname>Kendall</surname><given-names>AC</given-names></name><name><surname>Maidstone</surname><given-names>R</given-names></name><name><surname>Warwood</surname><given-names>S</given-names></name><name><surname>Loudon</surname><given-names>A</given-names></name><name><surname>Rattray</surname><given-names>M</given-names></name><name><surname>Bruce</surname><given-names>IN</given-names></name><name><surname>Nicolaou</surname><given-names>A</given-names></name><name><surname>Ray</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Rheumatoid arthritis reprograms circadian output pathways</article-title><source>Arthritis Research &amp; Therapy</source><volume>21</volume><elocation-id>47</elocation-id><pub-id pub-id-type="doi">10.1186/s13075-019-1825-y</pub-id><pub-id pub-id-type="pmid">30728072</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Scheer</surname><given-names>FAJL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circadian System and Glucose Metabolism: Implications for Physiology and Disease</article-title><source>Trends in Endocrinology and Metabolism</source><volume>27</volume><fpage>282</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2016.03.005</pub-id><pub-id pub-id-type="pmid">27079518</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinke</surname><given-names>H</given-names></name><name><surname>Asher</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Crosstalk between metabolism and circadian clocks</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>20</volume><fpage>227</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1038/s41580-018-0096-9</pub-id><pub-id pub-id-type="pmid">30635659</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rijo-Ferreira</surname><given-names>F</given-names></name><name><surname>Takahashi</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genomics of circadian rhythms in health and disease</article-title><source>Genome Medicine</source><volume>11</volume><elocation-id>82</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-019-0704-0</pub-id><pub-id pub-id-type="pmid">31847894</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>MS</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>In-vivo quantitative proteomics reveals a key contribution of post-transcriptional mechanisms to the circadian regulation of liver metabolism</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004047</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004047</pub-id><pub-id pub-id-type="pmid">24391516</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robles</surname><given-names>MS</given-names></name><name><surname>Humphrey</surname><given-names>SJ</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phosphorylation Is a Central Mechanism for Circadian Control of Metabolism and Physiology</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>118</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.10.004</pub-id><pub-id pub-id-type="pmid">27818261</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>P</given-names></name><name><surname>Wagg</surname><given-names>J</given-names></name><name><surname>Green</surname><given-names>ML</given-names></name><name><surname>Kaiser</surname><given-names>D</given-names></name><name><surname>Krummenacker</surname><given-names>M</given-names></name><name><surname>Karp</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Computational prediction of human metabolic pathways from the complete human genome</article-title><source>Genome Biology</source><volume>6</volume><elocation-id>R2</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2004-6-1-r2</pub-id><pub-id pub-id-type="pmid">15642094</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>C</given-names></name><name><surname>Suter</surname><given-names>DM</given-names></name><name><surname>Liani</surname><given-names>A</given-names></name><name><surname>Gos</surname><given-names>P</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><conf-name>The mammalian circadian timing system: Synchronization of peripheral clocks</conf-name><article-title>Cold spring harbor symposia on quantitative biology</article-title><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1101/sqb.2011.76.010918</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saltiel</surname><given-names>AR</given-names></name><name><surname>Olefsky</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inflammatory mechanisms linking obesity and metabolic disease</article-title><source>The Journal of Clinical Investigation</source><volume>127</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1172/JCI92035</pub-id><pub-id pub-id-type="pmid">28045402</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Helfrich-Förster</surname><given-names>C</given-names></name><name><surname>Yoshii</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A new ImageJ plug-in “ActogramJ” for chronobiological analyses</article-title><source>Journal of Biological Rhythms</source><volume>26</volume><fpage>464</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1177/0748730411414264</pub-id><pub-id pub-id-type="pmid">21921300</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitges</surname><given-names>FW</given-names></name><name><surname>Radovani</surname><given-names>E</given-names></name><name><surname>Najafabadi</surname><given-names>HS</given-names></name><name><surname>Barazandeh</surname><given-names>M</given-names></name><name><surname>Campitelli</surname><given-names>LF</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Jolma</surname><given-names>A</given-names></name><name><surname>Zhong</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Kanagalingam</surname><given-names>T</given-names></name><name><surname>Dai</surname><given-names>WF</given-names></name><name><surname>Taipale</surname><given-names>J</given-names></name><name><surname>Emili</surname><given-names>A</given-names></name><name><surname>Greenblatt</surname><given-names>JF</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multiparameter functional diversity of human C2H2 zinc finger proteins</article-title><source>Genome Research</source><volume>26</volume><fpage>1742</fpage><lpage>1752</lpage><pub-id pub-id-type="doi">10.1101/gr.209643.116</pub-id><pub-id pub-id-type="pmid">27852650</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuler</surname><given-names>M</given-names></name><name><surname>Dierich</surname><given-names>A</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Metzger</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse</article-title><source>Genesis</source><volume>39</volume><fpage>167</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/gene.20039</pub-id><pub-id pub-id-type="pmid">15282742</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Research</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinturel</surname><given-names>F</given-names></name><name><surname>Petrenko</surname><given-names>V</given-names></name><name><surname>Dibner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Circadian Clocks Make Metabolism Run</article-title><source>Journal of Molecular Biology</source><volume>432</volume><fpage>3680</fpage><lpage>3699</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2020.01.018</pub-id><pub-id pub-id-type="pmid">31996313</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Softic</surname><given-names>S</given-names></name><name><surname>Stanhope</surname><given-names>KL</given-names></name><name><surname>Boucher</surname><given-names>J</given-names></name><name><surname>Divanovic</surname><given-names>S</given-names></name><name><surname>Lanaspa</surname><given-names>MA</given-names></name><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Fructose and hepatic insulin resistance</article-title><source>Critical Reviews in Clinical Laboratory Sciences</source><volume>57</volume><fpage>308</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1080/10408363.2019.1711360</pub-id><pub-id pub-id-type="pmid">31935149</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenvers</surname><given-names>DJ</given-names></name><name><surname>Scheer</surname><given-names>FAJL</given-names></name><name><surname>Schrauwen</surname><given-names>P</given-names></name><name><surname>la Fleur</surname><given-names>SE</given-names></name><name><surname>Kalsbeek</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Circadian clocks and insulin resistance</article-title><source>Nature Reviews. Endocrinology</source><volume>15</volume><fpage>75</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/s41574-018-0122-1</pub-id><pub-id pub-id-type="pmid">30531917</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>SA</given-names></name><name><surname>Oursler</surname><given-names>MJ</given-names></name><name><surname>Rasmussen</surname><given-names>K</given-names></name><name><surname>Riggs</surname><given-names>BL</given-names></name><name><surname>Spelsberg</surname><given-names>TC</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts</article-title><source>Nucleic Acids Research</source><volume>23</volume><fpage>4907</fpage><lpage>4912</lpage><pub-id pub-id-type="doi">10.1093/nar/23.23.4907</pub-id><pub-id pub-id-type="pmid">8532536</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>I</given-names></name><name><surname>Imoto</surname><given-names>M</given-names></name><name><surname>Adjei</surname><given-names>PN</given-names></name><name><surname>Gores</surname><given-names>GJ</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Spelsberg</surname><given-names>TC</given-names></name><name><surname>Urrutia</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells</article-title><source>The Journal of Clinical Investigation</source><volume>99</volume><fpage>2365</fpage><lpage>2374</lpage><pub-id pub-id-type="doi">10.1172/JCI119418</pub-id><pub-id pub-id-type="pmid">9153278</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tognini</surname><given-names>P</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Eckel-Mahan</surname><given-names>KL</given-names></name><name><surname>Newman</surname><given-names>JC</given-names></name><name><surname>Verdin</surname><given-names>E</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Distinct Circadian Signatures in Liver and Gut Clocks Revealed by Ketogenic Diet</article-title><source>Cell Metabolism</source><volume>26</volume><fpage>523</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.08.015</pub-id><pub-id pub-id-type="pmid">28877456</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vollmers</surname><given-names>C</given-names></name><name><surname>Gill</surname><given-names>S</given-names></name><name><surname>DiTacchio</surname><given-names>L</given-names></name><name><surname>Pulivarthy</surname><given-names>SR</given-names></name><name><surname>Le</surname><given-names>HD</given-names></name><name><surname>Panda</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression</article-title><source>PNAS</source><volume>106</volume><fpage>21453</fpage><lpage>21458</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909591106</pub-id><pub-id pub-id-type="pmid">19940241</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wara</surname><given-names>AK</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Haemmig</surname><given-names>S</given-names></name><name><surname>Weber</surname><given-names>BN</given-names></name><name><surname>Aydogan</surname><given-names>CO</given-names></name><name><surname>Tesmenitsky</surname><given-names>Y</given-names></name><name><surname>Aliakbarian</surname><given-names>H</given-names></name><name><surname>Hawse</surname><given-names>JR</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Sage</surname><given-names>PT</given-names></name><name><surname>Tavakkoli</surname><given-names>A</given-names></name><name><surname>Garza</surname><given-names>A</given-names></name><name><surname>Lynch</surname><given-names>L</given-names></name><name><surname>Banks</surname><given-names>AS</given-names></name><name><surname>Feinberg</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>KLF10 Deficiency in CD4+ T Cells Triggers Obesity</article-title><source>Insulin Resistance, and Fatty Liver. Cell Rep</source><volume>33</volume><elocation-id>108550</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108550</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidemann</surname><given-names>BJ</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Bass</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A day in the life of chromatin: how enhancer-promoter loops shape daily behavior</article-title><source>Genes &amp; Development</source><volume>32</volume><fpage>321</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1101/gad.314187.118</pub-id><pub-id pub-id-type="pmid">29593064</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>CC</given-names></name><name><surname>Hawse</surname><given-names>JR</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>VHS</given-names></name><name><surname>Yu</surname><given-names>WCY</given-names></name><name><surname>Hung</surname><given-names>WC</given-names></name><name><surname>Chen</surname><given-names>LT</given-names></name><name><surname>Cheng</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model</article-title><source>Oncogene</source><volume>36</volume><fpage>5532</fpage><lpage>5543</lpage><pub-id pub-id-type="doi">10.1038/onc.2017.155</pub-id><pub-id pub-id-type="pmid">28581520</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Anafi</surname><given-names>RC</given-names></name><name><surname>Hughes</surname><given-names>ME</given-names></name><name><surname>Kornacker</surname><given-names>K</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MetaCycle: an integrated R package to evaluate periodicity in large scale data</article-title><source>Bioinformatics</source><volume>32</volume><fpage>3351</fpage><lpage>3353</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw405</pub-id><pub-id pub-id-type="pmid">27378304</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Subramaniam</surname><given-names>M</given-names></name><name><surname>Spelsberg</surname><given-names>TC</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Kruppel-like factor 10 protects against acute viral myocarditis by negatively regulating cardiac MCP-1 expression</article-title><source>Cellular &amp; Molecular Immunology</source><volume>4</volume><elocation-id>539</elocation-id><pub-id pub-id-type="doi">10.1038/s41423-020-00539-x</pub-id><pub-id pub-id-type="pmid">32895486</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshitane</surname><given-names>H</given-names></name><name><surname>Ozaki</surname><given-names>H</given-names></name><name><surname>Terajima</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>NH</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Fujimori</surname><given-names>T</given-names></name><name><surname>Kosaka</surname><given-names>N</given-names></name><name><surname>Shimba</surname><given-names>S</given-names></name><name><surname>Sugano</surname><given-names>S</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><name><surname>Iwasaki</surname><given-names>W</given-names></name><name><surname>Fukada</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CLOCK-controlled polyphonic regulation of circadian rhythms through canonical and noncanonical E-boxes</article-title><source>Molecular and Cellular Biology</source><volume>34</volume><fpage>1776</fpage><lpage>1787</lpage><pub-id pub-id-type="doi">10.1128/MCB.01465-13</pub-id><pub-id pub-id-type="pmid">24591654</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Lahens</surname><given-names>NF</given-names></name><name><surname>Ballance</surname><given-names>HI</given-names></name><name><surname>Hughes</surname><given-names>ME</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A circadian gene expression atlas in mammals: implications for biology and medicine</article-title><source>PNAS</source><volume>111</volume><fpage>16219</fpage><lpage>16224</lpage><pub-id pub-id-type="doi">10.1073/pnas.1408886111</pub-id><pub-id pub-id-type="pmid">25349387</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Prosdocimo</surname><given-names>DA</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>F</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name><name><surname>Jain</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>KLF15 Establishes the Landscape of Diurnal Expression in the Heart</article-title><source>Cell Reports</source><volume>13</volume><fpage>2368</fpage><lpage>2375</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.11.038</pub-id><pub-id pub-id-type="pmid">26686628</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Podtelezhnikov</surname><given-names>AA</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name><name><surname>Anafi</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Discovering Biology in Periodic Data through Phase Set Enrichment Analysis (PSEA)</article-title><source>Journal of Biological Rhythms</source><volume>31</volume><fpage>244</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1177/0748730416631895</pub-id><pub-id pub-id-type="pmid">26955841</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name><name><surname>Henry</surname><given-names>RA</given-names></name><name><surname>Trefely</surname><given-names>S</given-names></name><name><surname>Wallace</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>JV</given-names></name><name><surname>Carrer</surname><given-names>A</given-names></name><name><surname>Sengupta</surname><given-names>A</given-names></name><name><surname>Campbell</surname><given-names>SL</given-names></name><name><surname>Kuo</surname><given-names>YM</given-names></name><name><surname>Frey</surname><given-names>AJ</given-names></name><name><surname>Meurs</surname><given-names>N</given-names></name><name><surname>Viola</surname><given-names>JM</given-names></name><name><surname>Blair</surname><given-names>IA</given-names></name><name><surname>Weljie</surname><given-names>AM</given-names></name><name><surname>Metallo</surname><given-names>CM</given-names></name><name><surname>Snyder</surname><given-names>NW</given-names></name><name><surname>Andrews</surname><given-names>AJ</given-names></name><name><surname>Wellen</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch</article-title><source>Cell Reports</source><volume>17</volume><fpage>1037</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.069</pub-id><pub-id pub-id-type="pmid">27760311</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Uehara</surname><given-names>K</given-names></name><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>Izzo</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Trefely</surname><given-names>S</given-names></name><name><surname>Fernandez</surname><given-names>S</given-names></name><name><surname>Carrer</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Schug</surname><given-names>ZT</given-names></name><name><surname>Snyder</surname><given-names>NW</given-names></name><name><surname>Gade</surname><given-names>TP</given-names></name><name><surname>Titchenell</surname><given-names>PM</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name><name><surname>Wellen</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate</article-title><source>Nature</source><volume>579</volume><fpage>586</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2101-7</pub-id><pub-id pub-id-type="pmid">32214246</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65574.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Tontonoz</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lamia</surname><given-names>Katja A</given-names></name><role>Reviewer</role><aff><institution>Scripps Research Institute</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/10.1101/2020.12.22.423999">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.12.22.423999v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper shows that loss of the KLF10 in hepatocytes results in reprogramming of the circadian transcriptome in liver and alters the temporal coordination of pathways associated with energy metabolism.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by David James as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Katja A Lamia (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>1. Further characterization of the hepatic Klf10KO model is needed to substantiate claims regarding altered circadian control of glucose and lipid metabolism. For example, it has been shown that animals deficient in transcription factors that regulate circadian metabolic genes demonstrate poor adaptation to prolonged fasting (e.g. Klf15, Srebp, etc). What are the effects of overnight fasting in these animals (this would further support the claims in Figure 2 and S2)? Are there changes in plasma chemistry throughout the dark-light cycle in the fed condition? Are there shifts in energy utilization throughout the dark-light cycle?</p><p>2. Figures 1 and 2 emphasize KLF10's role in regulation of the circadian transcriptome, but no further characterization of circadian regulation is pursued thereafter. While the title indicates that &quot;circadian timing and sugar signaling&quot; are &quot;integrated&quot;, the second half of the paper fails to demonstrate any role of circadian timing in transcriptional regulation of metabolism. The authors should demonstrate how transcriptional changes in response to fructose/high glucose are altered with the circadian cycle.</p><p>3. Given the strong circadian expression of Klf10 and the title claim that KLF10 integrates circadian timing and sugar signaling, some of the analyses in Figures3-6 should be performed at multiple time points. Importantly, how does SSW impact circadian rhythms in the liver? Does it alter the daily profile of Klf10 mRNA and/or protein expression? Recruitment of KLF10 to chromatin at key loci? In figure 4, are all of these measurements performed at ZT15? The increase in G6pase upon exposure to SSW is surprising. I would expect that exposure to high sugar would decrease gluconeogenesis. Given the strong daily rhythms in expression of many of these genes, they should be measured at additional time points. At a minimum, expression should also be measured at ZT6-9, when KLF10 protein peaks under normal conditions (which is also the time of peak expression for Pck1 and G6pase).</p><p>4. How does the concentration of fructose used to treat hepatocytes (5 mM) relate to the amount of fructose present in tissues of mice or people after consumption of high fructose containing food/drinks? Please clarify in the text and methods section that SSW is the &quot;sugar beverage&quot; described in the methods. Given that the SSW treatment includes not only glucose + fructose but also sucrose, authors should check how sucrose influences expression of Klf10 in hepatocytes. As noted above in point 2, it would also be nice to see how the SSW consumption affects the concentrations of glucose, fructose, and sucrose to which hepatocytes are exposed in vivo. Related to this point, a highly relevant paper &quot;Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding&quot; by J Lee (Int J Mol Sci 2020) should be cited and discussed.</p><p>5. The presentation and analysis of the data in Figure 3 are unclear. Given that the study involves two independent variables, it would be appropriate to use two-way ANOVA to analyze these data to evaluate whether there is a main effect of genotype, of SSW, and/or of an interaction between the two factors. Then, individual pairwise comparisons would be performed when a main effect is observed. For example, panel 3F is described as showing that &quot;only KLf10Δhep mice displayed an increase in liver mass&quot; but it is unclear from the data whether that conclusion is justified. It appears that SSW also causes increased liver mass in the control mice even if it does not reach statistical significance in the test used. That does not necessarily mean that the genotype has a significant impact on the effect of SSW on liver mass. Similarly, Figure 3H is described as showing that KLf10Δhep mice on SSW have a significant increase in glycemia but this seems to come from comparing the control and SSW conditions for Klf10∆<italic>hep</italic> mice while those mice seem to have lower glucose compared to the control mice in the absence of SSW treatment and it is unclear whether the overall statement is justified by the data. In Figure 3C, the horizontal lines showing which groups are being compared have almost no space between them so it is hard to see what is being compared. In Figure 3J, a repeated measures ANOVA should be used to compare the groups. In Figure 3K, the presentation is unclear. Do the symbols on the right apply to all pairwise comparisons that are &quot;boxed&quot;? So the p value is P&lt;0.05 for both genotypes comparing control to SSW for hexose-6-phosphate for example?</p><p>6. The RNA-seq analysis in Figure 5C and 5D is confusing. It is not clear looking at the figure and the corresponding Supplemental figure which comparisons are being made. Is the comparison between genotypes for each treatment or between treatments for each genotype? Are the DEGs in the LG group achieved through comparing to an untreated group or to HGF (in which case, DEGs should only be represented once in relation to one treatment group)?</p><p>7. Figure 6D: The ChIP-seq data reveals widespread role for Klf10 in different metabolic networks. However, it is not clear why the authors compared the KLF10 ChIP-seq data with the RNA-seq DEGs comparing Klf10flox/flox and Klf10∆<italic>hep</italic> under HGF condition. If the authors want to know which genes are direct targets of Klf10, it would be more informative to compare the ChIP-seq data with the RNA-seq data set (at the same time point) from Figure 2 and then perform pathway analysis (this may yield hits for carbohydrate metabolism related pathways, which are not currently seen in 6D). In Figure 6B and 6D, are there really 7913 + 5317 = 13,230 KLF10 binding sites within the -10 to +1 kb region of only 213 + 93 = 306 genes? This seems hard to believe. Please clarify the discrepancy between these figures.</p><p>8. Previously published papers, including those from this group, have shown sex differences in the metabolic profile of Klf10-/- mice, thus exploring the phenotype resultant of specifically knocking out hepatocyte Klf10 in both male and female animals is of importance.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65574.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>1. Further characterization of the hepatic Klf10KO model is needed to substantiate claims regarding altered circadian control of glucose and lipid metabolism. For example, it has been shown that animals deficient in transcription factors that regulate circadian metabolic genes demonstrate poor adaptation to prolonged fasting (e.g. Klf15, Srebp, etc). What are the effects of overnight fasting in these animals (this would further support the claims in Figure 2 and S2)? Are there changes in plasma chemistry throughout the dark-light cycle in the fed condition? Are there shifts in energy utilization throughout the dark-light cycle?</p></disp-quote><p>We have shown earlier that the response of systemic <italic>Klf10</italic> KO mice to a prolonged fasting is indistinguishable from that of WT mice in contrast to <italic>Klf15</italic> KO mice (Guillaumond et al., Mol Cell Biol 2010, PMID: 20385766; Gray et al., Cell Metab 2007, PMID<bold>:</bold> 17403374). We have also tested the response of hepatic <italic>Klf10</italic> KO mice to a 19 h overnight fast and found no significant difference between genotypes (112 ± 7 mg/dl in <italic>Klf10<sup>flox/flox</sup> vs</italic> 113 ± 6 mg/dl in <italic>Klf10<sup>Δhep</sup></italic> mice). This data is now reported in the result section. This is consistent with the observation that <italic>Klf10</italic> KO hepatocytes have an increased gluconeogenic capacity (see new supplemental Figure S2F). In Figure S2C and S2D we also show subtle changes in plasma glucose and hepatic glycogen levels during the resting phase but not during the active phase. Our view is that KLF10 and KLF15 seem to have different and complementary roles in the regulation of glucose homeostasis by regulating the hepatic response to fasting and feeding respectively. We unfortunately did not have the possibility to perform indirect calorimetry to determine if energy utilization is changed in <italic>Klf10<sup>Δhep</sup></italic> mice during the LD cycle.</p><disp-quote content-type="editor-comment"><p>2. Figures 1 and 2 emphasize KLF10's role in regulation of the circadian transcriptome, but no further characterization of circadian regulation is pursued thereafter. While the title indicates that &quot;circadian timing and sugar signaling&quot; are &quot;integrated&quot;, the second half of the paper fails to demonstrate any role of circadian timing in transcriptional regulation of metabolism. The authors should demonstrate how transcriptional changes in response to fructose/high glucose are altered with the circadian cycle.</p></disp-quote><p>We agree that this is an important point which is now addressed in Figure 4 and Figure 5 where we have included gene expression data at both ZT9 and ZT15 peak and trough of <italic>Klf10</italic>, respectively. In Figure 4, we show that <italic>Klf10</italic> is inducible by sugars at ZT15 but not at ZT9. Figure 5 shows that in <italic>Klf10<sup>Δhep</sup></italic> mice the chow + SSW diet changes the expression of lipogenic genes at ZT15 but not ZT9 while genes regulating glycolysis and gluconeogenesis are impacted at both ZTs.</p><disp-quote content-type="editor-comment"><p>3. Given the strong circadian expression of Klf10 and the title claim that KLF10 integrates circadian timing and sugar signaling, some of the analyses in Figures3-6 should be performed at multiple time points. Importantly, how does SSW impact circadian rhythms in the liver? Does it alter the daily profile of Klf10 mRNA and/or protein expression? Recruitment of KLF10 to chromatin at key loci? In figure 4, are all of these measurements performed at ZT15? The increase in G6pase upon exposure to SSW is surprising. I would expect that exposure to high sugar would decrease gluconeogenesis. Given the strong daily rhythms in expression of many of these genes, they should be measured at additional time points. At a minimum, expression should also be measured at ZT6-9, when KLF10 protein peaks under normal conditions (which is also the time of peak expression for Pck1 and G6pase).</p></disp-quote><p>As indicated for point 2 above, we are now providing data showing the impact of the chow + SSW diet on the expression of <italic>Klf10</italic> determined at ZT9 and ZT 15 corresponding to its peak and through (see Figure 4B in the revised manuscript). In Figure 5 we have also analyzed the expression of <italic>Slc2a4, Pklr, Pck1, Fasn</italic> and <italic>Elovl6</italic> at these time points. Interestingly, this data now shows that the impact of the hepatic <italic>Klf10</italic> knockout combined with the high sugar diet changes the expression of lipogenic genes in a time-dependent manner while genes regulating glycolysis and gluconeogenesis are impacted at both ZTs.</p><p>The experiment reported in Figure 5 (Figure 6 in the revised version) was performed with primary hepatocytes and not designed to allow a RNA-seq profiling around the clock.</p><p>The recruitment of KLF10 to chromatin loci was investigated in unchallenged mice, at ZT9 in as reported in Fig7 A-D. When upregulated upon feeding with chow+ SSW, KLF10 also binds to <italic>Acss2</italic> and <italic>Acacb</italic> at ZT15 (Figure 7E).</p><p>We agree that induction of the gluconeogenic gene <italic>G6Pase</italic> in mice fed chow + SSW seems paradoxical at first glance. However, this effect has been consistently observed in earlier studies (see for instance Argaud et al., J Biol Chem, 1997, PMID 9139747; Sun et al., J Biol Chem, 2019, PMID: 31481463; Gautier-Stein et al., Diabetes, 2012, PMID: 22787137). Notably, G6Pase is also augmented in diabetic mice and in type 2 diabetes patients (Clore JN et al., Diabetes 2000 PMID: 10866049 ; Gautier-Stein et al., Diabetes, 2012, PMID: 22787137). The current explanation for this effect is that glucotoxicity resulting from high sugar consumption or insulin resistance leads to an increased ROS production which in turn stimulates the transcriptional activity of the transcription factor HIF1a which is a positive regulator of the G6Pase promoter (Gautier-Stein et al., Diabetes, 2012, PMID: 22787137).</p><disp-quote content-type="editor-comment"><p>4. How does the concentration of fructose used to treat hepatocytes (5 mM) relate to the amount of fructose present in tissues of mice or people after consumption of high fructose containing food/drinks? Please clarify in the text and methods section that SSW is the &quot;sugar beverage&quot; described in the methods. Given that the SSW treatment includes not only glucose + fructose but also sucrose, authors should check how sucrose influences expression of Klf10 in hepatocytes. As noted above in point 2, it would also be nice to see how the SSW consumption affects the concentrations of glucose, fructose, and sucrose to which hepatocytes are exposed in vivo. Related to this point, a highly relevant paper &quot;Deletion of KLF10 Leads to Stress-Induced Liver Fibrosis upon High Sucrose Feeding&quot; by J Lee (Int J Mol Sci 2020) should be cited and discussed.</p></disp-quote><p>We have clarified the text and method section regarding the definition of the SSW beverage. At the organism level, the small intestine absorbs only monosaccharides. Sucrose being a disaccharide, it is first cleaved into glucose and fructose by the digestive enzyme sucrase. Unless we misunderstood this comment, looking at the effect of sucrose by itself in isolated hepatocytes on the expression of <italic>Klf10</italic> is therefore irrelevant<italic>.</italic> Measuring exactly how SSW consumption impacts on the concentration of fructose and glucose circulating in the liver would require metabolic flux analysis which was beyond the scope of our study. Further, as said above, sucrose is converted into glucose and fructose. The Rabinowitz’s lab has shown that dietary fructose is cleared by the small intestine upon conversion into glucose and glycerate (and other metabolites at lower concentration). Fructose derived glucose and glycerate are then found in the hepatic portal vein. However, upon excess of dietary fructose, the small intestine is overwhelmed and fructose is transported to hepatocytes by the portal blood (Jang et al., Cell Met 2018, PMID: 29414685). We agree that the paper by Lee et al., is highly relevant to our study and have cited and discussed it in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>5. The presentation and analysis of the data in Figure 3 are unclear. Given that the study involves two independent variables, it would be appropriate to use two-way ANOVA to analyze these data to evaluate whether there is a main effect of genotype, of SSW, and/or of an interaction between the two factors. Then, individual pairwise comparisons would be performed when a main effect is observed. For example, panel 3F is described as showing that &quot;only KLf10Δhep mice displayed an increase in liver mass&quot; but it is unclear from the data whether that conclusion is justified. It appears that SSW also causes increased liver mass in the control mice even if it does not reach statistical significance in the test used. That does not necessarily mean that the genotype has a significant impact on the effect of SSW on liver mass. Similarly, Figure 3H is described as showing that KLf10Δhep mice on SSW have a significant increase in glycemia but this seems to come from comparing the control and SSW conditions for Klf10∆hep mice while those mice seem to have lower glucose compared to the control mice in the absence of SSW treatment and it is unclear whether the overall statement is justified by the data. In Figure 3C, the horizontal lines showing which groups are being compared have almost no space between them so it is hard to see what is being compared. In Figure 3J, a repeated measures ANOVA should be used to compare the groups. In Figure 3K, the presentation is unclear. Do the symbols on the right apply to all pairwise comparisons that are &quot;boxed&quot;? So the p value is P&lt;0.05 for both genotypes comparing control to SSW for hexose-6-phosphate for example?</p></disp-quote><p>Figures 3, 4 and 5 (now Figures 3, 4, 5 and 6 in the revised manuscript) report experiments investigating the effect of two independent variables (genotype and diet). In all these experiments the number of replicates is too small (n=3-12) to guarantee that we do have a normal distribution of the data, which is the prerequisite for using parametric statistical tests including the two-way ANOVA. For this reason, as stated in the quantification and statistical analyses section, we have used the Kruskal-Wallis non parametric test followed by pairwise post-hoc testing using the Benjamini-Hochberg adjustment, which is the equivalent of a one-way ANOVA. We agree that a limitation of non-parametric tests is that an interaction between the two variables cannot be detected. However, when a statistical difference is detected between the two genotypes on the chow + SSW diet but not on the chow diet, we are quite confident that this difference is the result of a combined effect of the mutation and the diet. We agree that regarding Figure 3F (Figure 4E in the revised manuscript), the statement “only KLf10<sup>Δhep</sup> mice displayed an increase in liver mass” could confuse the readers. We have therefore replaced this sentence by “We also observed a trend for an increase in liver mass of mice fed a chow +SSW diet that reached significance in Klf10<sup>Δhep</sup> mice (Figure 4E)”.</p><p>Figure 3C (Figure 4B in the revised manuscript). The layout has been improved.</p><p>Figure 3H (Figure 4G in the revised manuscript). The point for this figure is that <italic>Klf10<sup>Δhep</sup></italic> mice on chow have a slightly but not significantly (<italic>p</italic> = 0.225) lower glycemia than the <italic>Klf10<sup>flox/flox</sup></italic>. In addition, no difference was detected between the two diets for <italic>Klf10<sup>flox/flox</sup></italic> mice (p = 0.624). Conversely, we do detect a statistically higher glycemia in <italic>Klf10<sup>Δhep</sup></italic> mice on chow + SSW compared to their controls on chow (<italic>p</italic> = 0.0353). To more accurately describe this data we have replaced the sentence in the result section “Compared to <italic>Klf10<sup>flox/flox</sup></italic> mice, <italic>Klf10<sup>Δhep</sup></italic> mice on the chow + SSW diet had a significant increase in glycemia” by “Glycemia was moderately increased in <italic>Klf10<sup>Δhep</sup></italic> mice on chow diet as compared to their control on chow”.</p><p>Figure 3J (Figure 4I in the revised manuscript). In the GTT experiment for which we have a large dataset (Fig5I), we performed a three-way ANOVA and we could detect a significant interaction between the genotype and diet as reported in the result section.</p><p>Figure 3K (Figure 4J in the revised manuscript). The symbols next to the metabolite names apply to all the comparisons indicated by the boxes in the heatmap. We have clarified this in the figure legend.</p><disp-quote content-type="editor-comment"><p>6. The RNA-seq analysis in Figure 5C and 5D is confusing. It is not clear looking at the figure and the corresponding Supplemental figure which comparisons are being made. Is the comparison between genotypes for each treatment or between treatments for each genotype? Are the DEGs in the LG group achieved through comparing to an untreated group or to HGF (in which case, DEGs should only be represented once in relation to one treatment group)?</p></disp-quote><p>The experiment reported in Figure 5 (Figure 6 in the revised manuscript) aimed at determining whether the transcriptional response of primary hepatocytes exposed to a shift from a low glucose (LG) containing medium to a high glucose/fructose (HGF) containing medium is changed in the absence of KLF10. To clarify which comparisons were made, we have improved the readability of the volcano plots in Figure 6C so that the reader can better understand that this panel displays DEGs in the HGF vs LG treatment for each genotype. As now indicated on the right of Figure 6C, downregulated genes in HGF are upregulated in LG (and <italic>vice versa</italic>). In Figure 6D, we use this DEG output (see table S3 for gene lists) in a pathway enrichment analysis to determine which metabolic processes are activated in <italic>Klf10<sup>flox/flox</sup></italic> and <italic>Klf10<sup>Δhep</sup></italic> hepatocytes when treated with either LG or HGF. The result of this analysis is presented based on significantly enriched pathways in the LG condition (down regulated genes in HGF) and in the HGF condition (upregulated genes in HGF) separately so that differences in the metabolic response between genotypes can easily be visualized.</p><disp-quote content-type="editor-comment"><p>7. Figure 6D: The ChIP-seq data reveals widespread role for Klf10 in different metabolic networks. However, it is not clear why the authors compared the KLF10 ChIP-seq data with the RNA-seq DEGs comparing Klf10flox/flox and Klf10∆hep under HGF condition. If the authors want to know which genes are direct targets of Klf10, it would be more informative to compare the ChIP-seq data with the RNA-seq data set (at the same time point) from Figure 2 and then perform pathway analysis (this may yield hits for carbohydrate metabolism related pathways, which are not currently seen in 6D). In Figure 6B and 6D, are there really 7913 + 5317 = 13,230 KLF10 binding sites within the -10 to +1 kb region of only 213 + 93 = 306 genes? This seems hard to believe. Please clarify the discrepancy between these figures.</p></disp-quote><p>The experiments reported in Figure 3-5 support a role for KLF10 in energy metabolism. Further, the experiment performed with primary hepatocytes revealed that KLF10 extensively modulates the transcriptional response to hexose sugars. To keep the focus of the paper on energy metabolism, we integrated the data obtained with the RNA-seq experiment comparing the response of <italic>Klf10<sup>flox/flox</sup></italic> and <italic>Klf10<sup>Δhep</sup></italic> primary hepatocytes to a high sugar treatment with the data obtained with the ChIP-seq experiment performed in <italic>Klf10<sup>flox/flox</sup></italic> liver. One advantage of using the primary hepatocyte RNA-seq data is that we are looking at a cell autonomous transcriptome response to the metabolic challenge. Additionally, the transcriptome that we determined in Figure 2 may be not so informative as the animals were unchallenged while the metabolic phenotype is mostly visible in high sugar fed animals as reported in the paper. Further, the difference we see between the circadian transcriptomes of <italic>Klf10<sup>flox/flox</sup></italic> and <italic>Klf10<sup>Δhep</sup></italic> mice as revealed by the PSEA, mainly reflects a compromised temporal coordination, therefore using a single time point for constructing the network may lead to a bias in the analysis. Finally, the time course RNA-seq in liver was done using pooled samples (3 per time point) which precludes statistical analysis when using one single time point whereas the triplicates available with the experiment in challenged hepatocytes allowed such statistical analysis and subsequent integration of the data.</p><p>The bargraph shown in Figure 6B (Figure 7B in the revised manuscript) reports the number of KLF10 binding sites identified in the -50/+1 kb region of putative target genes. The 13,230 KLF10 binding sites identified in the -10/+1 kb proximal region are present in 7,898 unique genes. The full HumanCyc network that we used in our analysis contains 6,161 nodes including 2,566 genes and 81,590 edges. As the list of genes bound by KLF10 only partially intersect with the gene list of this metabolic network, the 306 KLF10 bound genes reported in Figure 6D (Figure 7D in the revised manuscript) and supplemental table S5 should not be directly compared to the number of binding sites reported in Figure 6B but instead considered as the fraction (12 %) of the metabolic genes of the HumanCyc network that are potentially regulated by KLF10. To better visualize this, we have modified the scheme in Figure 7A to indicate that the metabolic network in Figure 7C results from the merging of ChIP-seq and DEGs data with the HumaCyc metabolic network. We have also clarified the associated text in the results and Discussion sections.</p><disp-quote content-type="editor-comment"><p>8. Previously published papers, including those from this group, have shown sex differences in the metabolic profile of Klf10-/- mice, thus exploring the phenotype resultant of specifically knocking out hepatocyte Klf10 in both male and female animals is of importance.</p></disp-quote><p>We agree this is definitely an important point. Accordingly, during the initial step of the project we collected liver samples from female mice around the clock to perform some pilot experiments comparing the impact of the hepatocyte specific loss of KLF10 on circadian gene expression between males and females. We measured expression of the <italic>Elovl6</italic> mRNA as a marker of fatty acid synthesis and for which the systemic deletion of <italic>Klf10</italic> caused an opposite phase shift between males and females resulting in an approximately 7 h phase difference (Guillaumond et al., Mol Cell Biol, 2010, PMID: 20385766). As seen in <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>, we did not observe this dramatic difference in the phase of <italic>Elovl6</italic> oscillation between male and female <italic>Klf10<sup>Δhep</sup></italic> mice in which the acrophase of <italic>Elovl6</italic> was similar. Based on this result, we hypothesize that the sex difference seen in the systemic <italic>Klf10</italic> knockout model may be attributable to the lack of KLF10 in extrahepatic tissues or non-parenchymal hepatic cells. Of course, we cannot exclude that some sex difference exists in <italic>Klf10<sup>Δhep</sup></italic> animals but not retrieving a major difference seen in the Klf10 KO model led us to not further explore the phenotype of <italic>Klf10<sup>Δhep</sup></italic> female mice in this study.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65574-sa2-fig1-v2.tif"/></fig></body></sub-article></article>